syndrome	score	normalized_score
CRANIOSYNOSTOSIS 4; CRS4	1.50384615	100.0
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	1.0416667	69.2668395633423
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.01756273	67.66401802471617
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.006325843	66.91680814556729
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0	66.49616385293136
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.517430401	34.407136727383985
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.500915751	33.30897585501017
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.5	33.24808192646568
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.5	33.24808192646568
BRANCHIOOTORENAL SYNDROME 1	0.5	33.24808192646568
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.3508769	23.331967834608612
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.334248751	22.226259714133658
CANAVAN DISEASE	0.333333	22.16536578558917
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.259705261	17.269403588924305
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.62404096323284
HYPERPARATHYROIDISM 2	0.25	16.62404096323284
DYSTONIA 6, TORSION	0.25	16.62404096323284
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.62404096323284
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.208014262	13.832150449698593
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.20175963300000002	13.416241614875299
PYLE DISEASE; PYL	0.2	13.299232770586276
OSTEOGENESIS IMPERFECTA, TYPE IV	0.2	13.299232770586276
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.19506043	12.97077031450325
CYSTINOSIS, NEPHROPATHIC; CTNS	0.13354099	8.87996355212267
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.12995974	8.641824165324358
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.125	8.31202048161642
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.125	8.31202048161642
TARP SYNDROME; TARPS	0.12313773200000001	8.188186803550352
JOUBERT SYNDROME 2	0.12050952200000001	8.013420920750438
COFFIN-SIRIS SYNDROME 4; CSS4	0.12041712300000001	8.00727674170659
COFFIN-SIRIS SYNDROME 3; CSS3	0.12041712300000001	8.00727674170659
COFFIN-SIRIS SYNDROME 2; CSS2	0.12041712300000001	8.00727674170659
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.116929131	7.775338654156877
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.11256138200000002	7.4849001009844
ACROCALLOSAL SYNDROME; ACLS	0.11061833100000001	7.355694663313798
TURNPENNY-FRY SYNDROME; TPFS	0.10783908200000002	7.1708852664217035
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.10547739300000002	7.013842007708036
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.10448024200000001	6.947535291425923
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.103105183	6.856099142854474
JOUBERT SYNDROME 7	0.10195747200000001	6.779780764142663
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.10091575100000001	6.710510313837623
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.10012607100000001	6.65799962316624
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.09597728000000001	6.382120937038674
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.093626192	6.225782604158011
HEART AND BRAIN MALFORMATION SYNDROME	0.089719133	5.965978168710942
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.08717945000000002	5.797098991808439
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.08717945000000002	5.797098991808439
#602398 DESMOSTEROLOSIS	0.085139923	5.66147827023396
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.08495293300000001	5.649044152555101
TYROSINEMIA, TYPE I; TYRSN1	0.08333330000000001	5.541344771205487
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.08333330000000001	5.541344771205487
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.08333330000000001	5.541344771205487
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.08333330000000001	5.541344771205487
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.08333330000000001	5.541344771205487
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.08168009100000001	5.431412714658345
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.08051171100000001	5.353719926735858
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.07766913000000002	5.164699194794628
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.07740785100000001	5.147325143599298
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.07691056100000002	5.114257266276874
COSTELLO SYNDROME; CSTLO	0.07637124199999999	5.078394621683873
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.07476004200000001	4.971256002484031
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.07347119300000002	4.8855524881983445
XIA-GIBBS SYNDROME	0.07287920199999999	4.846187357662882
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.07142860000000001	4.749727889385494
MARSHALL-SMITH SYNDROME; MRSHSS	0.07025157	4.6714599096456775
HALLERMANN-STREIFF SYNDROME; HSS	0.06837220000000001	4.546489014185394
DYSOSTEOSCLEROSIS	0.065206001	4.335948926690406
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.065096641	4.32867690621145
COFFIN-SIRIS SYNDROME 6; CSS6	0.060145362	3.999435846545872
CORNELIA DE LANGE SYNDROME 3	0.059709383	3.9704449155254347
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	3.914609217172913
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.058481551	3.888798797669562
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.058113561	3.8643288743333217
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.057932082	3.8522612170134556
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	3.8121851759902436
MARFANOID HABITUS WITH SITUS INVERSUS	0.05719781	3.803434945788836
WHITE-SUTTON SYNDROME; WHSUS	0.056903511999999996	3.783865257759246
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.055533702	3.6927781475518624
MUCOPOLYSACCHARIDOSIS, TYPE II	0.053547351	3.5606934259864285
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.05314998	3.5342697788600246
POTOCKI-LUPSKI SYNDROME	0.053115673	3.531988494966723
HURLER-SCHEIE SYNDROME	0.0526316	3.4997994974419426
SCHEIE SYNDROME	0.0526316	3.4997994974419426
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0526316	3.4997994974419426
APNEA, OBSTRUCTIVE SLEEP	0.0526316	3.4997994974419426
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.0526316	3.4997994974419426
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0526316	3.4997994974419426
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.052588162	3.4969110370764986
CHROMOSOME 1P36 DELETION SYNDROME	0.052316053	3.4788168324266415
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.050440201	3.354079870470792
CHROMOSOME 3q13.31 DELETION SYNDROME	0.04981871	3.3127531031016706
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.049783982	3.310443824323386
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.049479199999999994	3.2901769905119616
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.04856456099999999	3.2293570057016803
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.047945673	3.1882033278470674
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.047459732	3.15589011548821
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.046891663	3.1181157061844393
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.04662643999999999	3.1004793941188726
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.04662643999999999	3.1004793941188726
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.04662643999999999	3.1004793941188726
ACRORENAL-MANDIBULAR SYNDROME	0.04652602	3.0938018493447617
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.046331553	3.0808705398487737
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.045664813	3.03653488756147
LOWE OCULOCEREBRORENAL SYNDROME	0.045186620999999996	3.0047369539763094
CRANIOSYNOSTOSIS 6; CRS6	0.044605802	2.9661147185834134
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.044537953	2.9616030203621557
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.044013871999999996	2.9267536443139477
CHROMOSOME 18Q DELETION SYNDROME	0.043989051	2.9251031430309546
COWDEN SYNDROME 5; CWS5	0.043943461	2.9220715829208994
COWDEN SYNDROME 6; CWS6	0.043943461	2.9220715829208994
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.043794761999999994	2.9121836698521317
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.043746201	2.9089545496392697
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0434457	2.8889723859053
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.043222621999999995	2.8741385546653158
SILVER-RUSSELL SYNDROME; SRS	0.043151532	2.869411342377011
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.04278028999999999	2.8447251735159207
ZUNICH NEUROECTODERMAL SYNDROME	0.04263037099999999	2.834756135127253
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.04258245099999999	2.8315696389554206
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.04230765	2.813296426632472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.042284882999999995	2.8117825084700314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.04218774299999999	2.805323071113358
MOWAT-WILSON SYNDROME; MOWS	0.041707790999999994	2.7734081042798158
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.041666699999999994	2.7706757104109347
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.041666699999999994	2.7706757104109347
HYPOPHOSPHATEMIC BONE DISEASE	0.041666699999999994	2.7706757104109347
HYPOPHOSPHATASIA, ADULT	0.041666699999999994	2.7706757104109347
RENAL TUBULAR ACIDOSIS III	0.041666699999999994	2.7706757104109347
#607748 HYPERCHOLANEMIA, FAMILIAL; FHCA	0.041666699999999994	2.7706757104109347
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.041666699999999994	2.7706757104109347
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.041666699999999994	2.7706757104109347
DENT DISEASE 1	0.041666699999999994	2.7706757104109347
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.041666699999999994	2.7706757104109347
#219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;;CYSTINOSIS, INTERMEDIATE	0.041666699999999994	2.7706757104109347
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.041410591999999996	2.7536455108788886
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.041285142999999996	2.7453036336197023
KAGAMI-OGATA SYNDROME	0.040810072999999995	2.7137133010580903
CRANIOLENTICULOSUTURAL DYSPLASIA	0.04080179999999999	2.7131631782945345
BEEMER LETHAL MALFORMATION SYNDROME	0.04078806	2.7122495210031956
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.040601029999999996	2.6998127434777817
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.040299882999999995	2.6797876232219626
BRANCHIOOCULOFACIAL SYNDROME	0.040058921	2.663764574587633
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.039881812999999995	2.651987571999968
WILLIAMS-BEUREN SYNDROME; WBS	0.039439590000000004	2.622581438932434
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.039430020999999996	2.6219451371405245
HYPOADRENOCORTICISM, FAMILIAL	0.039377251	2.6184361345740053
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.039343602	2.616198605156518
DUBOWITZ SYNDROME	0.03932691	2.615088651189485
OSTEOPENIA AND SPARSE HAIR	0.039229089999999994	2.608583996441391
THROMBOCYTOPENIA 3	0.0392156	2.6076869631910156
MENKES DISEASE	0.03913506099999999	2.6023314286504635
CRI-DU-CHAT SYNDROME	0.03903492	2.5956724363060677
CRANIOFRONTONASAL SYNDROME; CFNS	0.038997161999999995	2.5931616741513084
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.038879910000000004	2.5853648659472253
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.038660841999999994	2.5707976843242903
THUMBS, CONGENITAL CLASPED	0.0384757	2.5584864515562313
PREPAPILLARY VASCULAR LOOPS	0.0384615	2.55754220602952
ARTERIES, ANOMALIES OF	0.0384615	2.55754220602952
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	2.55754220602952
MUSCULAR HYPERTONIA, LETHAL	0.0384615	2.55754220602952
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	2.55754220602952
THUMB DEFORMITY	0.0384615	2.55754220602952
WATSON SYNDROME	0.0384615	2.55754220602952
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	2.55754220602952
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	2.55754220602952
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	2.55754220602952
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	2.55754220602952
BETHLEM MYOPATHY 1	0.0384615	2.55754220602952
ATROPHODERMA VERMICULATA; AVA	0.0384615	2.55754220602952
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	2.55754220602952
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	2.55754220602952
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	2.55754220602952
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.038367519999999995	2.551292896550621
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.038367519999999995	2.551292896550621
AL KAISSI SYNDROME; ALKAS	0.038185042999999995	2.539158876059229
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.037902311999999994	2.5203583491569264
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.037705372	2.5072625946477305
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.037688782	2.50615942328941
Muenke syndrome	0.037365713	2.4846765741296077
GABRIELE-DE VRIES SYNDROME; GADEVS	0.037185612	2.4727005485235307
FRANK-TER HAAR SYNDROME; FTHS	0.037121100000000004	2.468410748001051
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.037013313	2.4612433259878346
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.03696467	2.4580087530895365
Contractural arachnodactyly, congenital	0.03671008	2.4410794947342187
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.036610782999999994	2.4344766251521137
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03594484	2.390193970307401
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.03592098	2.3886073718378706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03581621	2.3816405687509987
SCHAAF-YANG SYNDROME; SHFYNG	0.035678783	2.372502200441182
BARAITSER-WINTER SYNDROME 2; BRWS2	0.035025711	2.3290754177214206
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.035002820000000004	2.3275532540346635
Pierpont syndrome	0.034942593	2.3235483895742925
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.034354813	2.2844632743848163
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.034280859999999996	2.2795456835794004
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.034123222999999994	2.2690634277981157
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.034123222999999994	2.2690634277981157
RESTRICTIVE DERMOPATHY, LETHAL	0.0340907	2.2669007730611272
ZTTK SYNDROME; ZTTKS	0.033971423	2.2589693101252415
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.033826483	2.249331356136397
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.03362298	2.235799187303834
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.033343463	2.217212379072154
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.03330824	2.2148701846927628
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.033301301	2.214408767811787
METACHROMATIC LEUKODYSTROPHY	0.033279341	2.212948512053577
LISSENCEPHALY 5; LIS5	0.033279341	2.212948512053577
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.033247023	2.210799489030178
PEROXISOME BIOGENESIS DISORDER 6B	0.033207471999999995	2.2081694992536303
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.033207471999999995	2.2081694992536303
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.033207471999999995	2.2081694992536303
LISSENCEPHALY 1; LIS1	0.033009633	2.19501396469313
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.033009633	2.19501396469313
PALLISTER-KILLIAN SYNDROME	0.032852291	2.1845513252801827
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.032825383	2.1827620465032274
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.032786909999999996	2.1802037395913136
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.032773252999999995	2.179295601481574
WITTEVEEN-KOLK SYNDROME	0.032729443000000004	2.176382404543178
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.032678491999999996	2.172994358498707
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.032678491999999996	2.172994358498707
PRADER-WILLI SYNDROME; PWS	0.032562003	2.1652482868676426
FACIOCARDIORENAL SYNDROME	0.03255633	2.164871054130105
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.032555671	2.164827233158126
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.03253618	2.1635311564284683
BOHRING-OPITZ SYNDROME	0.032386553	2.1535815349196454
COFFIN-SIRIS SYNDROME 1; CSS1	0.032384483000000006	2.1534438878604707
Adrenoleukodystrophy	0.032165751	2.138899048948591
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.032165751	2.138899048948591
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.032165751	2.138899048948591
MEGALENCEPHALY WITH DYSMYELINATION	0.032165751	2.138899048948591
OCULODENTODIGITAL DYSPLASIA; ODDD	0.032165751	2.138899048948591
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.032093882	2.1341200361486443
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.031929371	2.123180685737035
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.031819929999999996	2.115903279068806
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.031705462	2.108291596184889
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.031676583	2.1063712534689802
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.031676583	2.1063712534689802
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.031571892	2.0994097035790524
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.031552223	2.0981017905322292
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	2.078005120404105
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.03125	2.078005120404105
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03125	2.078005120404105
MYELOCEREBELLAR DISORDER	0.03125	2.078005120404105
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03125	2.078005120404105
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03125	2.078005120404105
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.03125	2.078005120404105
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	2.0759271817798646
15q13.3 microdeletion syndrome	0.031218750999999996	2.0759271817798646
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.031214810000000003	2.0756651203981207
YUNIS-VARON SYNDROME	0.03116821	2.072566399162574
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	2.0711481689799185
INFANTILE SIALIC ACID STORAGE DISEASE	0.031093923	2.067626598638431
SMITH-MAGENIS SYNDROME; SMS	0.030856203000000002	2.0518191305673126
TRISOMY 18-LIKE SYNDROME	0.03070407	2.041702869671874
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.030470683	2.0261835294787303
CLEFT CHIN	0.030302999999999997	2.0150332532353787
15q24 recurrent microdeletion syndrome	0.030302999999999997	2.0150332532353787
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	2.0150332532353787
NASAL BONES, ABSENCE OF	0.030302999999999997	2.0150332532353787
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	2.0150332532353787
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	2.0150332532353787
OROFACIAL CLEFT 3	0.030302999999999997	2.0150332532353787
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	2.0150332532353787
DWARFISM, LEVI TYPE	0.030302999999999997	2.0150332532353787
CYANIDE, INABILITY TO SMELL	0.030302999999999997	2.0150332532353787
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.030302999999999997	2.0150332532353787
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	2.0150332532353787
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	2.0150332532353787
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	2.0150332532353787
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	2.0150332532353787
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	2.0150332532353787
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	2.0150332532353787
Growth hormone deficiency, isolated, type IA	0.030302999999999997	2.0150332532353787
22q11.2 distal deletion syndrome	0.030302999999999997	2.0150332532353787
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	2.0150332532353787
DIMPLES, FACIAL	0.030302999999999997	2.0150332532353787
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	2.0150332532353787
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	2.0150332532353787
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	2.0150332532353787
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.030232352999999997	2.010335498747661
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.030152482	2.005024383644564
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.029996242000000003	1.9946350230041816
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.029980332999999998	1.993577135533445
EMANUEL SYNDROME	0.029930093	1.990236368261474
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02990003	1.9882372940875632
311450 PALLISTER W SYNDROME;;W SYNDROME	0.029686771	1.9740563886804512
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.029568282999999997	1.9661773912178448
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.029521953	1.9630966239465388
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.029405342999999997	1.9553425062796483
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.029348131	1.9515381277532944
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.029210082999999998	1.9423584653257246
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.029210033	1.9423551405175326
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.029189023	1.9409580561149824
KLEEFSTRA SYNDROME 2; KLEFS2	0.029189023	1.9409580561149824
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.029131610000000002	1.937140311859694
KOOLEN-DE VRIES SYNDROME; KDVS	0.029093083000000002	1.9345784141549323
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.029055143	1.9320555496983516
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.02904444	1.9313438412566342
ROBINOW-SORAUF SYNDROME	0.02880336	1.9153129460749694
GAUCHER DISEASE, PERINATAL LETHAL	0.028506350999999996	1.8955629869451736
OROFACIODIGITAL SYNDROME VI	0.028428072000000002	1.8903577337349302
BAND HETEROTOPIA; BH	0.028409683	1.8891349357778389
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.028227993000000003	1.8770532477673998
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02812224	1.8700210789514604
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02807812	1.8670872682022694
TEMPLE SYNDROME	0.027972109999999998	1.8600380098722198
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.027941942	1.858031953601105
FONTAINE PROGEROID SYNDROME; FPS	0.02791941	1.8565336620371704
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.027775389999999997	1.8469568845190711
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.027741502	1.844703462518423
TENORIO SYNDROME; TNORS	0.027562371	1.8327919381912836
TYSHCHENKO SYNDROME	0.027440482	1.8246867872754136
MARFAN SYNDROME; MFS	0.02733663	1.8177810276669593
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.027232171	1.810834904887046
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.027230111	1.8106979227895086
RAINE SYNDROME	0.027159682	1.8060146644655106
Temtamy preaxial brachydactyly syndrome	0.027159682	1.8060146644655106
PITT-HOPKINS SYNDROME	0.027104591	1.8023513243026887
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.02699522	1.79507857236593
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.026985413	1.7944264444870244
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.02696993	1.7933968843820893
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.02690649	1.7891783677472592
ATELOSTEOGENESIS, TYPE I; AO1	0.026858519999999997	1.785988546767234
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.026840283	1.7847758562270482
CAMPOMELIC DYSPLASIA	0.02672201	1.7769111554396706
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0266804	1.77414425006175
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02665005	1.7721260914888137
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02665005	1.7721260914888137
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.026649293000000004	1.7720757538927772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.026632373	1.7709506388003855
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.026585400999999998	1.7678271809918853
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.026525889999999996	1.763869927784833
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0263158	1.7498997487209713
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.02606121	1.7329704903656535
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.026026179999999996	1.730641129745885
KNIEST-LIKE DYSPLASIA, LETHAL	0.026026179999999996	1.730641129745885
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.025858192999999998	1.7194706386687229
OHDO SYNDROME	0.025813771000000003	1.7165167460780482
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.025729563	1.7109172371123205
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.025722622	1.710455687239017
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.025670619999999998	1.706997753726337
CORNELIA DE LANGE SYNDROME 1	0.025573131	1.7005151092084785
HAMAMY SYNDROME; HMMS	0.025550589999999998	1.6990162191790694
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.025506789999999998	1.6961036872023112
PETERS-PLUS SYNDROME; PTRPLS	0.025436393	1.6914225567555567
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.025391623000000002	1.6884455234998608
MEHMO SYNDROME; MEHMO	0.025275923000000002	1.6807519173420766
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.025228469999999996	1.677596474878763
PACHYGYRIA, FRONTOTEMPORAL	0.025145461	1.6720766948134953
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.02510977	1.6697033802294203
HAREL-YOON SYNDROME; HAYOS	0.025075732000000003	1.6674399838041944
Xq28 (MECP2) duplication	0.025038143	1.6649404595011266
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.025029282	1.6643512369932258
OROFACIODIGITAL SYNDROME I; OFD1	0.024964320999999998	1.6600315796931755
TEEBI-SHALTOUT SYNDROME; TBSH	0.024924870000000002	1.6574082395330134
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.024860092	1.6531007510309483
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.024744603	1.6454211755637371
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.02473889	1.645041282979645
MENTAL RETARDATION, X-LINKED 98; MRX98	0.024662253	1.6399452164704482
MICROPHTHALMIA, SYNDROMIC 3	0.024652252	1.6392801883357548
OROFACIODIGITAL SYNDROME IX; OFD9	0.024619952	1.6371323622433054
OROFACIODIGITAL SYNDROME VIII; OFD8	0.024619952	1.6371323622433054
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.024607993000000005	1.6363371346197884
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.02458615	1.6348846589127486
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.024486831	1.6282803264150392
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.024475872	1.627551594955375
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.02422971	1.6111827662690097
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.024200703	1.6092539120441278
FOCAL DERMAL HYPOPLASIA; FDH	0.023898680000000002	1.589170541148774
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.02389268	1.5887715641656561
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.023844449999999996	1.5855644541830292
15q26 overgrowth syndrome	0.02366782	1.573819236761686
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.023659150000000004	1.5732427150210813
GAUCHER DISEASE, TYPE II	0.023647932999999996	1.5724968275511424
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.023614302	1.570260495064605
COHEN-GIBSON SYNDROME; COGIS	0.023590522	1.568679216288182
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.023479512	1.5612974771388684
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.023417520999999997	1.557175313445461
#614976 CARPENTER SYNDROME 2; CRPT2	0.023351261999999998	1.5527693441247297
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.023326550999999997	1.5511261574197597
OROFACIODIGITAL SYNDROME XIV; OFD14	0.023287662	1.5485401881036833
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.023214200999999997	1.5436553134108828
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.023180033000000003	1.5413832724843564
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.023161880000000003	1.540176167621934
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.02311826	1.5372756049546692
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.023104160999999998	1.5363380755405065
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.022939242000000002	1.5253715946940452
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.022931223	1.5248383619561083
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.022904683000000002	1.5230735537674516
Diamond-Blackfan anemia 1	0.022895759999999998	1.5224802084973919
PHELAN-MCDERMID SYNDROME; PHMDS	0.022811843000000002	1.5169000499153455
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.02271405	1.5103971905636757
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.022697093	1.5092696151132217
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.02267974	1.5081157071818816
FANCONI ANEMIA	0.02263563	1.5051825613943288
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.02263563	1.5051825613943288
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.02263563	1.5051825613943288
FRONTONASAL DYSPLASIA 1; FND1	0.02244331	1.4923940191621332
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.022431101999999998	1.4915822339938163
WARBURG MICRO SYNDROME 1	0.022408760000000003	1.4900965767010146
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.022386603	1.488623221198525
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.022383381	1.4884089705585908
ROIFMAN SYNDROME; RFMN	0.022365672	1.4872313899929193
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.022365671999999996	1.4872313899929188
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.022273963	1.4811330933021307
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.02221197	1.477010796616396
SCLEROSTEOSIS 1; SOST1	0.02218841	1.4754441469960209
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.022177411	1.4747127556898025
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.022167832999999998	1.474075855432419
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.022167832999999998	1.474075855432419
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.02209536	1.4692566789495056
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.021850803	1.452994576606124
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.021785503	1.4486523771065278
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.021779653	1.448263374547988
BARAITSER-WINTER SYNDROME 1; BRWS1	0.021773983	1.447886341298942
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.021619811	1.4376344947254078
CRANIOECTODERMAL DYSPLASIA 1	0.02157253	1.4344904896022774
SHORT SYNDROME	0.02157253	1.4344904896022774
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.02152179	1.4311164742483795
NEMALINE MYOPATHY 10	0.02152179	1.4311164742483795
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02152179	1.4311164742483795
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	1.4311164742483795
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	1.4311164742483795
ENDOCARDIAL FIBROELASTOSIS	0.02147207	1.4278102849816119
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.021456893	1.4268010727028162
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	1.4179609396878794
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.021288510000000004	1.4156042491447682
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.021288510000000004	1.4156042491447682
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.021288510000000004	1.4156042491447682
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.021229582	1.4116857632012423
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.02118246	1.4085523309681647
MARTSOLF SYNDROME	0.02117159	1.4078295176670832
ADAMS-OLIVER SYNDROME 1; AOS1	0.021163353	1.4072817887654265
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.021134322	1.4053513386326122
CHROMOSOME 10Q26 DELETION SYNDROME	0.021065443	1.400771149362586
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.021005692	1.3967979370762096
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.020947211	1.3929091749179263
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.020942810000000003	1.3926165253008098
MENTAL RETARDATION, X-LINKED 19	0.02094281	1.3926165253008094
SCHOLTE SYNDROME; SHLTS	0.02094281	1.3926165253008094
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.020929863	1.3917555994674056
RAHMAN SYNDROME	0.020919772000000003	1.3910845866779658
POTOCKI-SHAFFER SYNDROME	0.020878640999999996	1.3883495329625306
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.02085288	1.3866365252855155
Helsmoortel-van der Aa syndrome	0.020761843000000006	1.3805829140168364
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.020761843000000006	1.3805829140168364
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.020744971	1.3794609907403095
CHAR SYNDROME	0.020714122	1.3774096505816105
LARSEN-LIKE SYNDROME	0.020670862	1.3745330265333326
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.020625043	1.371486238801755
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.020534073	1.365437082776054
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.020523551	1.3647374101399934
HHHH SYNDROME	0.020523551	1.3647374101399934
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020523551	1.3647374101399934
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	1.359958397340047
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.020417123000000002	1.3576603564134537
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.3570670111433938
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.3570670111433938
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.3570670111433938
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.3570670111433938
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	1.3570670111433938
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.3570670111433938
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	1.3570670111433938
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.3570670111433938
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.3570670111433938
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.3570670111433938
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.3570670111433938
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.3570670111433938
RECOMBINANT CHROMOSOME 8 SYNDROME	0.020385653	1.3555677221370017
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.020354553	1.3534996914411757
611961 STEVENSON-CAREY SYNDROME	0.020343303	1.3527516095978303
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.020330550000000003	1.3519035840202138
CHROMOSOME 2q37 DELETION SYNDROME	0.020327053	1.35167104693522
DESANTO-SHINAWI SYNDROME	0.020313943	1.3507992822271082
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02017268	1.3414058346327515
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.02014807	1.339769364040331
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.02014807	1.339769364040331
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.020091092000000005	1.335980545616319
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.02001435	1.3308774970099169
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.019865831	1.3210015532506434
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.019723169999999998	1.3115151440192203
KLEEFSTRA SYNDROME	0.019632951	1.3055159266125727
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.019623623000000003	1.3048956503961529
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.019622031999999998	1.3047898549994623
PLATELET SIGNAL PROCESSING DEFECT	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.0196078	1.3038434815955078
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.3038434815955078
VESICOURETERAL REFLUX 1	0.0196078	1.3038434815955078
MEGAEPIPHYSEAL DWARFISM	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.0196078	1.3038434815955078
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.0196078	1.3038434815955078
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.3038434815955078
#614009 BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13;;BLEEDING DISORDER, SUSCEPTIBILITY TO, DUE TO DEFECTIVE PLATELET THROMBOXANEA2 RECEPTOR	0.0196078	1.3038434815955078
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.0196078	1.3038434815955078
FACTOR V DEFICIENCY	0.0196078	1.3038434815955078
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.0196078	1.3038434815955078
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.3038434815955078
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.0196078	1.3038434815955078
EPISTAXIS, HEREDITARY	0.0196078	1.3038434815955078
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0196078	1.3038434815955078
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.3038434815955078
PUBIC BONE DYSPLASIA	0.0196078	1.3038434815955078
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 20	0.0196078	1.3038434815955078
Glanzmann thrombasthenia	0.0196078	1.3038434815955078
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.0196078	1.3038434815955078
VAN DEN BOSCH SYNDROME	0.0196078	1.3038434815955078
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	0.0196078	1.3038434815955078
GAUCHER DISEASE, TYPE I	0.0196078	1.3038434815955078
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.3038434815955078
KNUCKLE PADS	0.0196078	1.3038434815955078
RAYNAUD DISEASE	0.0196078	1.3038434815955078
#613625 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2	0.0196078	1.3038434815955078
%605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12;;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;;PGHS1 DEFICIENCY;;PLATELET CYCLOOXYGENASE 1 DEFICIENCY;;PLATELET COX1 DEFICIENCY	0.0196078	1.3038434815955078
CARPAL DISPLACEMENT	0.0196078	1.3038434815955078
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.3038434815955078
TRACHEOBRONCHOMEGALY	0.0196078	1.3038434815955078
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.0196078	1.3038434815955078
#215300 CHONDROSARCOMA	0.0196078	1.3038434815955078
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.3038434815955078
SPINAL ARACHNOIDITIS	0.0196078	1.3038434815955078
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.0196078	1.3038434815955078
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.3038434815955078
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	1.3038434815955078
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.0196078	1.3038434815955078
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.0196078	1.3038434815955078
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.3038434815955078
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.3038434815955078
NEPHROSIALIDOSIS	0.0196078	1.3038434815955078
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.0196078	1.3038434815955078
THROMBOCYTOPENIA 1	0.0196078	1.3038434815955078
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.3038434815955078
STORMORKEN SYNDROME; STRMK	0.0196078	1.3038434815955078
PURPURA SIMPLEX	0.0196078	1.3038434815955078
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.3038434815955078
Congenital prothrombin deficiency	0.0196078	1.3038434815955078
THROMBOCYTOPENIA 5; THC5	0.0196078	1.3038434815955078
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.3038434815955078
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0196078	1.3038434815955078
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	0.0196078	1.3038434815955078
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.3038434815955078
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0196078	1.3038434815955078
#614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7	0.0196078	1.3038434815955078
MONOPHALANGY OF GREAT TOE	0.0196078	1.3038434815955078
LETTERER-SIWE DISEASE	0.0196078	1.3038434815955078
#227500 FACTOR VII DEFICIENCY;;F7 DEFICIENCY;;HYPOPROCONVERTINEMIA	0.0196078	1.3038434815955078
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.3038434815955078
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.3038434815955078
SEBASTIAN SYNDROME	0.0196078	1.3038434815955078
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.0196078	1.3038434815955078
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	1.3038434815955078
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.0196078	1.3038434815955078
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.0196078	1.3038434815955078
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.3038434815955078
Bernard-Soulier syndrome	0.0196078	1.3038434815955078
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	1.3038434815955078
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.0196078	1.3038434815955078
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.3038434815955078
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	0.0196078	1.3038434815955078
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.0196078	1.3038434815955078
168830 PASSOVOY FACTOR DEFECT	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	0.0196078	1.3038434815955078
TOE, MISSHAPEN	0.0196078	1.3038434815955078
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.3038434815955078
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0196078	1.3038434815955078
BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18	0.0196078	1.3038434815955078
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.019501372000000003	1.2967664278689681
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.019500703	1.2967219419353504
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.019490073	1.2960150877135934
SWEENEY-COX SYNDROME; SWCOS	0.019479681999999998	1.2953241260749977
MOEBIUS SYNDROME; MBS	0.01940074	1.2900747859081196
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.01940074	1.2900747859081196
WARBURG MICRO SYNDROME 3; WARBM3	0.019367220999999997	1.2878459009919332
HYPEREKPLEXIA 2; HKPX2	0.01927211	1.281521384351717
#154780 MARSHALL SYNDROME; MRSHS	0.01927211	1.281521384351717
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.019140073	1.2727414303650677
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.018888293000000004	1.2559990262301768
PALMOMENTAL REFLEX	0.0188679	1.2546429699607236
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2546429699607236
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2546429699607236
DIASTEMATOMYELIA	0.0188679	1.2546429699607236
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2546429699607236
ALCOHOL DEPENDENCE	0.0188679	1.2546429699607236
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2546429699607236
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2546429699607236
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2546429699607236
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2546429699607236
269800 SENILE PLAQUE FORMATION	0.0188679	1.2546429699607236
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2546429699607236
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2546429699607236
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2546429699607236
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2546429699607236
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2546429699607236
TRANSSEXUALITY	0.0188679	1.2546429699607236
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2546429699607236
MOTION SICKNESS	0.0188679	1.2546429699607236
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2546429699607236
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2546429699607236
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2546429699607236
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2546429699607236
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2546429699607236
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2546429699607236
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2546429699607236
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2546429699607236
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2546429699607236
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.2546429699607236
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2546429699607236
CERVICAL RIB	0.0188679	1.2546429699607236
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2546429699607236
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2546429699607236
MYOPATHY, CONGENITAL	0.0188679	1.2546429699607236
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2546429699607236
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2546429699607236
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2546429699607236
ERYTHERMALGIA, PRIMARY	0.0188679	1.2546429699607236
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2546429699607236
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2546429699607236
CARDIAC ARRHYTHMIA	0.0188679	1.2546429699607236
RHEUMATOID ARTHRITIS	0.0188679	1.2546429699607236
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2546429699607236
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.2546429699607236
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2546429699607236
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2546429699607236
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01881847	1.2513560645814734
VAN MALDERGEM SYNDROME 2; VMLDS2	0.018750850000000003	1.2468595939817382
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.018732502	1.2456395223673646
GOLDBERG-SHPRINTZEN SYNDROME	0.018701872	1.2436027448685494
ROBERTS SYNDROME; RBS	0.01866123	1.2409002077772384
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.018604002	1.2370947653122628
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.01855205	1.2336401566077755
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01849249	1.2296796450886949
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.018484073	1.2291199468775447
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.01834226	1.219689926393069
TEMTAMY SYNDROME; TEMTYS	0.018327833	1.2187305862371627
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.018315963	1.2179412767722284
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.018315963	1.2179412767722284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.018290533	1.2162502793254484
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.018290533	1.2162502793254484
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.018274283000000002	1.2151697166628384
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.018274283000000002	1.2151697166628384
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.018218712	1.211474458341367
MIRAGE SYNDROME; MIRAGE	0.018178503	1.2088007140890042
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.018149143	1.2068483867182824
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.018044681	1.1999020644498775
BASAL CELL NEVUS SYNDROME	0.01803459	1.1992310516604374
MICROPHTHALMIA, SYNDROMIC 12	0.01800523	1.1972787242897154
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.01784314	1.1865003610907938
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.01758833	1.1695564735794284
CHROMOSOME 5Q12 DELETION SYNDROME	0.017579123000000002	1.1689442433988344
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.017579123000000002	1.1689442433988344
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.017579123000000002	1.1689442433988344
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.017579123000000002	1.1689442433988344
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.017579123000000002	1.1689442433988344
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0175439	1.1666020490194426
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0175439	1.1666020490194426
184705 STEINFELD SYNDROME	0.0175439	1.1666020490194426
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.0175439	1.1666020490194426
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.0175439	1.1666020490194426
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0175439	1.1666020490194426
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.0175439	1.1666020490194426
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0175439	1.1666020490194426
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0175439	1.1666020490194426
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.0175439	1.1666020490194426
AUROCEPHALOSYNDACTYLY	0.0175439	1.1666020490194426
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0175439	1.1666020490194426
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.0175439	1.1666020490194426
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.0175439	1.1666020490194426
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.017543231	1.166557563085825
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.017407363000000002	1.157522862295455
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.017397983000000002	1.1568991282785146
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.017386732999999998	1.1561510464351687
FACIOCARDIOMELIC SYNDROME	0.01733631	1.1527981103652127
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.017319672	1.1516917471910277
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.017304542	1.1506856602319326
CHOPS SYNDROME; CHOPS	0.017262752	1.1479067855445186
CODAS SYNDROME	0.017258343	1.1476136039580909
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.017246661	1.146836795771961
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.017242280999999998	1.1465455425742852
C SYNDROME	0.017219293	1.1450169287596341
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.017136111	1.1394856448580195
MEIER-GORLIN SYNDROME 1; MGORS1	0.0171346	1.1393851691544377
MEIER-GORLIN SYNDROME 6; MGORS6	0.0171346	1.1393851691544377
#300867 KABUKI SYNDROME 2; KABUK2	0.017125483000000004	1.1387789236285908
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.01700632	1.1308550412553837
METAPHYSEAL ACROSCYPHODYSPLASIA	0.01700632	1.1308550412553837
Rothmund-Thomson syndrome	0.0170024	1.1305943762930803
HUNTER-MACDONALD SYNDROME	0.01698691	1.1295643507149984
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.016952323000000002	1.1272644478958171
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.016772790000000003	1.1153261921108089
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.016759073	1.114414064231238
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0167444	1.113438366019024
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.016735240999999998	1.1128293276542947
ANGELMAN SYNDROME	0.016729713	1.112461736860516
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.016663372	1.1080503148543486
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.016644561	1.1067994555161111
FETAL AKINESIA SYNDROME, X-LINKED	0.01656606	1.101579440157492
CLARK-BARAITSER SYNDROME	0.016526601000000002	1.0989555680280194
ATKIN-FLAITZ SYNDROME	0.016526601000000002	1.0989555680280194
LAMB-SHAFFER SYNDROME	0.016493752	1.0967712355416144
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.016465533	1.0948947802938485
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01644914	1.0938047086798075
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.01632653	1.0856516140297994
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01632653	1.0856516140297994
GENITOPATELLAR SYNDROME; GTPTS	0.016298732	1.0838031536670159
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.016264681	1.0815388927916594
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.016244942000000002	1.0802263250133666
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.016244942000000002	1.0802263250133666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.016167523	1.0750782585040364
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01614668	1.0736922789608498
WEBB-DATTANI SYNDROME; WEDAS	0.016144752999999998	1.0735641408531051
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.016128503000000002	1.0724835781904953
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.016125361	1.0722746472436693
GERODERMA OSTEODYSPLASTICUM; GO	0.01587702	1.0557609234162684
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.01587702	1.0557609234162684
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.015864343	1.0549179515471048
ZIMMERMANN-LABAND SYNDROME 1	0.015849891	1.0539569489871023
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.01581949	1.051935399109809
CHROMOSOME 9P DELETION SYNDROME	0.015778022	1.0491779361871558
JACOBSEN SYNDROME	0.01572913	1.0459268057440585
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.015718503	1.0452201510107932
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.01564773	1.0405140180064296
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.01561085	1.0380616394835336
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.015549782	1.0340008517493626
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.015549782	1.0340008517493626
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.015549782	1.0340008517493626
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.01536585	1.0217700793395654
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.01532132	1.0188090051631944
MECKEL SYNDROME, TYPE 1; MKS1	0.0152644	1.0150240435166855
#256520 NEU-LAXOVA SYNDROME; NLS	0.0152644	1.0150240435166855
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.015212752000000001	1.0115896496460095
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.015168671	1.0086584322472083
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.015164522	1.0083825396633823
HEMIFACIAL MICROSOMIA	0.01514779	1.0072699258497952
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.015011771	0.9982251841386833
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.014990283	0.9967963145698114
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.014916092999999998	0.9918629641735625
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.014903851	0.9910489181356749
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.014896912	0.9905875012546994
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.014873673	0.9890421969029213
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.01486724	0.9886144270808553
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.01486724	0.9886144270808553
LOEYS-DIETZ SYNDROME 5	0.01486724	0.9886144270808553
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.014844782	0.9871210562330461
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0147059	0.9778859360048233
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0147059	0.9778859360048233
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.0147059	0.9778859360048233
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	0.0147059	0.9778859360048233
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.0147059	0.9778859360048233
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.0147059	0.9778859360048233
DUANE RETRACTION SYNDROME 1	0.0147059	0.9778859360048233
ACHALASIA-MICROCEPHALY SYNDROME	0.0147059	0.9778859360048233
#221900 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE	0.0147059	0.9778859360048233
EVEN-PLUS SYNDROME	0.014688852	0.9767523094034586
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.014637923	0.9733657262745927
SHASHI-PENA SYNDROME; SHAPNS	0.014637923	0.9733657262745927
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.01461522	0.9718560638666395
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.014606159999999998	0.971253608622132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.014521973	0.9656554960758453
JABERI-ELAHI SYNDROME; JABELS	0.014481683	0.9629763656342107
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.014450040999999999	0.960872294017576
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014390363	0.956903935951161
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01435576	0.9546029691933581
CEREBROOCULONASAL SYNDROME	0.0142331	0.9464465497351575
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.014213842	0.9451659666116777
FRYNS SYNDROME; FRNS	0.014198530999999999	0.9441478438469254
MARDEN-WALKER SYNDROME	0.014163321	0.9418065139176637
OCULOCEREBROCUTANEOUS SYNDROME	0.014146401	0.9406813988252721
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.014096922	0.9373912351339929
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.014090020000000002	0.9369322786110801
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.014086052000000002	0.9366684218329117
#278250 WRINKLY SKIN SYNDROME; WSS	0.01405303	0.9344725855101601
CROUZON SYNDROME	0.014052181	0.934416130267049
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.013893613	0.9238719665572173
KBG SYNDROME	0.013887613	0.9234729895740997
ELSAHY-WATERS SYNDROME; ESWS	0.013887132	0.9234410049192865
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.01387295	0.9224979563235243
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013872949999999998	0.922497956323524
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.013856489999999999	0.9214034294665049
RENPENNING SYNDROME 1; RENS1	0.013842391	0.9204659000523425
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.0138147	0.9186245547790909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.013810290999999999	0.9183313731926632
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.013810290999999997	0.9183313731926632
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.013790552	0.9170188054143703
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.013790552	0.9170188054143703
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.013771003	0.9157188719072094
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.013744319999999999	0.9139445547671216
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.013722172000000001	0.9124717977301069
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.013711323	0.9117503808484664
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.013689162000000001	0.9102767593613217
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.013675111	0.9093424217630242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.013674112999999998	0.9092760585914986
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.013639853	0.9069979000178976
Pontine tegmental cap dysplasia	0.013639852999999999	0.9069979000178974
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.013582932999999998	0.9032129383713885
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.013557502999999999	0.9015219409246085
FLYNN-AIRD SYNDROME	0.013546480999999999	0.9007890202066215
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.013524333000000001	0.899316263169607
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013511223000000001	0.898444498461495
OCULOECTODERMAL SYNDROME; OES	0.013501533	0.89780015063376
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.013499703	0.8976784626539092
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013499703	0.8976784626539092
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.013499703	0.8976784626539092
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.01343048	0.8930753987035177
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.01343048	0.8930753987035177
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.013406332	0.8914696493387971
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.01336996	0.8890510508671382
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.01336996	0.8890510508671382
CRANIOECTODERMAL DYSPLASIA 3	0.01336996	0.8890510508671382
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01325304	0.8812763193894535
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.01325304	0.8812763193894535
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.013222592000000002	0.8792516441924596
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.013173283000000001	0.8759727848490353
SCHINDLER DISEASE, TYPE I	0.013173283000000001	0.8759727848490353
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.01316017	0.8751008206524318
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.01316017	0.8751008206524318
SIMOSA CRANIOFACIAL SYNDROME	0.01316017	0.8751008206524318
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.01316017	0.8751008206524318
DEAFNESS, X-LINKED 7; DFNX7	0.01316017	0.8751008206524318
WAARDENBURG SYNDROME, TYPE 1; WS1	0.01316017	0.8751008206524318
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.01316017	0.8751008206524318
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.01315625	0.8748401556901283
MCDONOUGH SYNDROME	0.01315625	0.8748401556901283
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.01310049	0.8711323295936888
WARBURG MICRO SYNDROME 2; WARBM2	0.01299112	0.8638596441530937
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.012972099999999999	0.8625948871166109
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.012946669999999999	0.8609038896698309
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.012929261	0.8597462579533153
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.012917740999999998	0.8589802221457294
CHARGE SYNDROME	0.01291699	0.8589302835266759
NOONAN SYNDROME 3; NS3	0.012912182	0.8586105699708709
TONNE-KALSCHEUER SYNDROME; TOKAS	0.012892842	0.8573245341619554
POPOV-CHANG SYNDROME; POPCHAS	0.012886752	0.8569195725240909
VERVERI-BRADY SYNDROME; VERBRAS	0.01287829	0.8563568819855675
CHIARI MALFORMATION TYPE II	0.01285068	0.8545209229015881
FUMARASE DEFICIENCY; FMRD	0.012845872	0.8542012093457831
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.01284528	0.8541618436167823
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.012826421	0.8529077924626797
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.012791162999999998	0.8505632707175529
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.012774260999999999	0.8494393525561108
NOONAN SYNDROME 6; NS6	0.012764212	0.8487711326055528
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.012758361999999999	0.848382130047013
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.012713621	0.845407025180069
LISSENCEPHALY, X-LINKED, 2	0.012707950999999999	0.8450299919310228
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.012702392	0.8446603397561645
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.012698030999999999	0.8443703499856018
MICROPHTHALMIA, SYNDROMIC 1	0.012698030999999999	0.8443703499856018
RETT SYNDROME, CONGENITAL VARIANT	0.012696700999999998	0.8442819100876773
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.012696700999999998	0.8442819100876773
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.012678211	0.8430523960180368
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.012676962	0.8429693423093845
Mental retardation, autosomal dominant 21	0.012667181999999999	0.8423190098269027
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01266023	0.8418567284957972
LISSENCEPHALY 3; LIS3	0.012655820999999998	0.8415635469093695
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.012652841	0.8413653883410879
HOLOPROSENCEPHALY 7	0.012648033	0.841045674785283
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.012641752	0.8406280123801226
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.012641752	0.8406280123801226
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.012641752	0.8406280123801226
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.01263073	0.8398950916621357
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.01263073	0.8398950916621357
HURLER SYNDROME	0.012608582000000002	0.8384223346251212
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.012574400999999999	0.8361494292484639
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.012564500999999999	0.83549111722632
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.01256245	0.8353547335942575
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.012560522999999999	0.8352265954865129
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.012507339999999999	0.8316901300043225
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.012443913	0.8274724778196227
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.012443913	0.8274724778196227
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0124207	0.8259289023681047
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0124207	0.8259289023681047
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.012403032999999999	0.8247541146413148
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.012386113	0.8236289995489233
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.012378710000000001	0.8231367284479201
ROIFMAN-CHITAYAT SYNDROME	0.012292742	0.8174201862338113
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.012257532	0.8150788563045495
ADENYLOSUCCINASE DEFICIENCY	0.012163502999999999	0.8088262885136221
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.012163502999999999	0.8088262885136221
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.012146582999999999	0.8077011734212306
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.012133979999999999	0.8068631222681921
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.012133979999999999	0.8068631222681921
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.012127563	0.8064364163847478
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.012059693	0.8019233217440493
LAMBOTTE SYNDROME	0.01201137	0.7987100276181842
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.011927542	0.7931357871947207
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.011811103	0.7853930403718491
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.011797869999999998	0.7845130966355832
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0117922	0.7841360633865372
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.011764700000000001	0.7823074188805818
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.011764700000000001	0.7823074188805818
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.011764700000000001	0.7823074188805818
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.011764700000000001	0.7823074188805818
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.011764700000000001	0.7823074188805818
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.011764700000000001	0.7823074188805818
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.01166567	0.7757223037742258
COLE-CARPENTER SYNDROME 2; CLCRP2	0.01165865	0.7752555007039782
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.01165865	0.7752555007039782
COLE-CARPENTER SYNDROME 1; CLCRP1	0.01165865	0.7752555007039782
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.01164875	0.7745971886818341
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.01164875	0.7745971886818341
TOWNES-BROCKS SYNDROME 1; TBS1	0.011644772	0.7743326669420273
Myhre syndrome	0.011625460999999998	0.7730485595218631
KABUKI SYNDROME 1	0.011601313	0.7714428101571427
COFFIN-LOWRY SYNDROME; CLS	0.011553151	0.7682402219136578
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.011553151	0.7682402219136578
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.011542231	0.7675140838043839
BAKER-GORDON SYNDROME; BAGOS	0.011528162	0.766578549275137
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.011512572	0.7655418740806698
PRIMROSE SYNDROME; PRIMS	0.011500539999999998	0.7647417922371912
CDAGS SYNDROME	0.011492752	0.7642239201131047
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.011481282	0.7634612091137116
JOUBERT SYNDROME 35; JBTS35	0.011481282	0.7634612091137116
INCONTINENTIA PIGMENTI; IP	0.011467831	0.7625667692137257
MENTAL RETARDATION, X-LINKED 104; MRX104	0.011467783	0.7625635773978608
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.01141365	0.75896394056001
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.011395962	0.7577877564137795
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.011354831	0.7550527026983445
AYME-GRIPP SYNDROME; AYGRP	0.011354831	0.7550527026983445
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.011319621	0.7527113727690828
MENTAL RETARDATION, X-LINKED 1	0.011319621	0.7527113727690828
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.011283443	0.7503056745532114
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.011228571	0.7466568970502734
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.011223763	0.7463371834944684
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.011152293	0.7415847026638995
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.011152293	0.7415847026638995
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.011069942999999999	0.7361087435706105
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.011069942999999999	0.7361087435706105
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.011069942999999999	0.7361087435706105
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.011069942999999999	0.7361087435706105
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.011049913	0.7347768254086364
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.011028072	0.7333244826939246
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.011020683	0.7328331425392152
SMITH-KINGSMORE SYNDROME; SKS	0.010967221	0.7292781246273097
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.010950301	0.7281530095349182
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.010930562	0.7268404417566252
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.010930562	0.7268404417566252
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.010930562	0.7268404417566252
OROFACIODIGITAL SYNDROME V; OFD5	0.0108884	0.7240368304962578
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0108884	0.7240368304962578
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.0108884	0.7240368304962578
MEIER-GORLIN SYNDROME 3; MGORS3	0.010800889999999999	0.7182177511974878
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.010800889999999999	0.7182177511974878
MEIER-GORLIN SYNDROME 5; MGORS5	0.010800889999999999	0.7182177511974878
PSEUDOTRISOMY 13 SYNDROME	0.010760009999999999	0.71549938801918
GLYCEROL KINASE DEFICIENCY; GKD	0.010697513	0.7113435772668635
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01069013	0.7108526360891373
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.010685562	0.710548881612657
MECKEL SYNDROME 12; MKS12	0.01067861	0.7100866002815515
OROFACIODIGITAL SYNDROME XV; OFD15	0.01067861	0.7100866002815515
STROMME SYNDROME; STROMS	0.01067861	0.7100866002815515
PSEUDODIASTROPHIC DYSPLASIA	0.01064887	0.7081090043685653
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.01064887	0.7081090043685653
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01064887	0.7081090043685653
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.010573691	0.7031098892662657
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.010562170999999999	0.7023438534586799
MELNICK-NEEDLES SYNDROME	0.01055208	0.70167284066924
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.010552032	0.701669648853375
MEIER-GORLIN SYNDROME 7	0.010501822000000001	0.6983308764663194
HARTSFIELD SYNDROME; HRTFDS	0.010490302	0.6975648406587336
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.01043908	0.6941587741538587
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.01043908	0.6941587741538587
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.01043908	0.6941587741538587
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.010435593	0.6939269020305036
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.01041667	0.6926685951219145
CREE MENTAL RETARDATION SYNDROME	0.010250772	0.681637014531041
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.010179622	0.6769058124729049
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.010179622	0.6769058124729049
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.010179622	0.6769058124729049
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010134881	0.6739307076059609
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.010134162	0.6738828968641507
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.010107911999999998	0.6721373725630111
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.010093860999999999	0.6712030349647136
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.010093812999999998	0.6711998431488486
OMODYSPLASIA 1; OMOD1	0.01008668	0.6707255260120858
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.010055623	0.6686603546513052
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010046092	0.668026579713623
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.010038703	0.6675352395589136
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.010038703	0.6675352395589136
YOU-HOOVER-FONG SYNDROME; YHFS	0.010021992	0.6664240221647674
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.010021992	0.6664240221647674
MEVALONIC ACIDURIA; MEVA	0.010021992	0.6664240221647674
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.009981783	0.6637502779124047
PALLISTER-HALL SYNDROME	0.009981783	0.6637502779124047
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.009970070000000001	0.6629714083451954
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.009956353	0.6620592804656247
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.009926993	0.6601069530949027
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.009926993	0.6601069530949027
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.009915473	0.6593409172873168
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.009915473	0.6593409172873168
HOLOPROSENCEPHALY 2; HPE2	0.009915473	0.6593409172873168
VICI SYNDROME; VICIS	0.009915473	0.6593409172873168
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009915473	0.6593409172873168
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009915473	0.6593409172873168
HOLOPROSENCEPHALY 1; HPE1	0.009915473	0.6593409172873168
HYPEREKPLEXIA 4; HKPX4	0.009824153	0.6532684876042673
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.009824153	0.6532684876042673
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.009675943	0.6434130911596243
STUVE-WIEDEMANN SYNDROME	0.00965458	0.6419925336112341
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.009572133	0.6365101243900515
3MC SYNDROME 2	0.009571972	0.6364994185076711
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.009571972	0.6364994185076711
Aarskog-Scott syndrome	0.009571972	0.6364994185076711
MASA SYNDROME	0.00952981	0.6336958072473038
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.00952381	0.6332968302641864
TELECANTHUS	0.00952381	0.6332968302641864
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00952381	0.6332968302641864
OROFACIODIGITAL SYNDROME X	0.00952381	0.6332968302641864
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00952381	0.6332968302641864
2p15-16.1 microdeletion syndrome	0.00952381	0.6332968302641864
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00952381	0.6332968302641864
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00952381	0.6332968302641864
FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	0.00952381	0.6332968302641864
BARBER-SAY SYNDROME; BBRSAY	0.00952381	0.6332968302641864
22q11 duplication syndrome	0.00952381	0.6332968302641864
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00952381	0.6332968302641864
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009519842	0.6330329734860178
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00946413	0.6293283392054433
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00946413	0.6293283392054433
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00946413	0.6293283392054433
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.009456741	0.628836999050734
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.009439982	0.6277225898407227
CHROMOSOME 16Q22 DELETION SYNDROME	0.009439982	0.6277225898407227
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00940689	0.6255220987865016
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00939266	0.6245758583748744
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009387851999999999	0.6242561448190693
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.009335739999999999	0.6207908967283654
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.009335739999999999	0.6207908967283654
LATERAL MENINGOCELE SYNDROME	0.009335739999999999	0.6207908967283654
CRANIOSYNOSTOSIS 2	0.009328111	0.6202835974943315
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.009310309999999999	0.6190998992815854
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.009310309999999999	0.6190998992815854
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.009310309999999999	0.6190998992815854
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.009310309999999999	0.6190998992815854
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00926105	0.61582429825019
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.009256242000000001	0.6155045846943852
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00925434	0.6153781089907369
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00925434	0.6153781089907369
FEINGOLD SYNDROME 1; FGLDS1	0.00925434	0.6153781089907369
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00925434	0.6153781089907369
GLUTAMINE DEFICIENCY, CONGENITAL	0.009249931	0.6150849274043093
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.009249931	0.6150849274043093
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.009242143	0.6145670552802227
NOONAN SYNDROME 7; NS7	0.009211740999999999	0.6125454389067657
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009206932999999999	0.6122257253509609
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.009199721	0.6117461550172535
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.009190013	0.6111006102585694
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00917811	0.6103091064202278
NEMALINE MYOPATHY 4	0.00917811	0.6103091064202278
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00917811	0.6103091064202278
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00917811	0.6103091064202278
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.009139871999999999	0.6077664261068194
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.009139871999999999	0.6077664261068194
KAPUR-TORIELLO SYNDROME	0.009137900999999999	0.6076353621678653
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.009122952	0.6066413110144279
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.009122952	0.6066413110144279
RETT SYNDROME; RTT	0.009112470999999999	0.6059443647210853
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.009071590999999999	0.6032260015427774
GLYCINE ENCEPHALOPATHY; GCE	0.009071590999999999	0.6032260015427774
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009066032	0.602856349367919
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.009066032	0.602856349367919
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.009040602	0.6011653519211391
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.009040602	0.6011653519211391
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.009040602	0.6011653519211391
LYMPHEDEMA, HEREDITARY, III	0.009040602	0.6011653519211391
OPTIC ATROPHY 11; OPA11	0.009011242000000001	0.599213024550417
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.008999722	0.5984469887428312
WIEDEMANN-STEINER SYNDROME; WDSTS	0.008997142999999999	0.5982754951362544
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.008997142999999999	0.5982754951362544
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.008994321999999999	0.5980879094580253
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.008994321999999999	0.5980879094580253
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.008994321999999999	0.5980879094580253
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.008980271	0.5971535718597278
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.008980271	0.5971535718597278
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.008980222999999999	0.5971503800438628
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.008980222999999999	0.5971503800438628
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008945013	0.5948090501146012
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.008945013	0.5948090501146012
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.008945013	0.5948090501146012
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.008945013	0.5948090501146012
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.008945013	0.5948090501146012
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.008945013	0.5948090501146012
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.008945013	0.5948090501146012
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00892609	0.5935507432060121
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00892609	0.5935507432060121
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00892609	0.5935507432060121
OSTEOGENESIS IMPERFECTA, TYPE X	0.00892609	0.5935507432060121
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.008908402000000001	0.5923745590597815
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.008908402000000001	0.5923745590597815
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.008908402000000001	0.5923745590597815
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.008908402000000001	0.5923745590597815
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.008908402000000001	0.5923745590597815
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.008908402000000001	0.5923745590597815
SECKEL SYNDROME 8; SCKL8	0.008908402000000001	0.5923745590597815
ASPARTYLGLUCOSAMINURIA; AGU	0.008832061	0.5872981754150849
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.008832061	0.5872981754150849
CHROMOSOME 16p13.3 DELETION SYNDROME	0.008813403000000001	0.5860574899899169
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.008801883	0.5852914541823311
LISSENCEPHALY 4	0.008801883	0.5852914541823311
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008801883	0.5852914541823311
GABA-TRANSAMINASE DEFICIENCY	0.008801883	0.5852914541823311
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.008801883	0.5852914541823311
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.008801883	0.5852914541823311
RITSCHER-SCHINZEL SYNDROME 1	0.008760192	0.5825191626151386
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.008728251	0.580395208645512
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.008728251	0.580395208645512
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.008728251	0.580395208645512
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.008728251	0.580395208645512
SCARF SYNDROME	0.00872809	0.5803845027631318
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00872809	0.5803845027631318
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.008656382	0.5756161958455658
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.008656382	0.5756161958455658
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.008656382	0.5756161958455658
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.008656382	0.5756161958455658
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.008656382	0.5756161958455658
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.008656382	0.5756161958455658
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00854397	0.56814122907453
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.008491203	0.5646324259965023
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.008491203	0.5646324259965023
TIMOTHY SYNDROME; TS	0.008491203	0.5646324259965023
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.008407791999999999	0.5590859144733655
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.008363051	0.5561108096064216
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.008346131	0.5549856945140299
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.008346131	0.5549856945140299
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.008346131	0.5549856945140299
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.008346131	0.5549856945140299
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0083312	0.5539928402915418
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.008326392	0.553673126735737
JOUBERT SYNDROME 10	0.008326392	0.553673126735737
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00829599	0.5516515103622801
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00829599	0.5516515103622801
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00822215	0.5467414336233796
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00822215	0.5467414336233796
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00822215	0.5467414336233796
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.00822215	0.5467414336233796
NOONAN SYNDROME 8; NS8	0.00822215	0.5467414336233796
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.008217741	0.546448252036952
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.008217741	0.546448252036952
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.008209953	0.5459303799128655
GASTROESOPHAGEAL REFLUX	0.00819672	0.5450504361765995
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00819672	0.5450504361765995
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.00819672	0.5450504361765995
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00819672	0.5450504361765995
#614266 BARRETT ESOPHAGUS;;BARRETT METAPLASIAADENOCARCINOMA OF ESOPHAGUS, INCLUDED	0.00819672	0.5450504361765995
MEIER-GORLIN SYNDROME 2; MGORS2	0.00819672	0.5450504361765995
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00819672	0.5450504361765995
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00816736	0.5430981088058775
SENGERS SYNDROME	0.00816736	0.5430981088058775
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.00815044	0.541972993713486
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.008136341	0.5410354642993234
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.008136341	0.5410354642993234
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.008101131000000001	0.5386941343700618
CHROMOSOME 19p13.13 DELETION SYNDROME	0.008093343	0.538176262245975
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.008081392	0.5373815665917687
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00806452	0.5362596433152421
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00806452	0.5362596433152421
%109500 BASILAR IMPRESSION, PRIMARY	0.00806452	0.5362596433152421
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00806452	0.5362596433152421
#614815 JOUBERT SYNDROME 18; JBTS18	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00806452	0.5362596433152421
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00806452	0.5362596433152421
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00806452	0.5362596433152421
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.00806452	0.5362596433152421
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00806452	0.5362596433152421
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.00806452	0.5362596433152421
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00806452	0.5362596433152421
DYSTONIA, JUVENILE-ONSET	0.00806452	0.5362596433152421
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.00806452	0.5362596433152421
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00806452	0.5362596433152421
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00806452	0.5362596433152421
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00806452	0.5362596433152421
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00806452	0.5362596433152421
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00806452	0.5362596433152421
PROTEUS SYNDROME	0.00806452	0.5362596433152421
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.00806452	0.5362596433152421
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00806452	0.5362596433152421
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00806452	0.5362596433152421
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00806452	0.5362596433152421
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00806452	0.5362596433152421
OROFACIODIGITAL SYNDROME XI; OFD11	0.00806452	0.5362596433152421
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00806452	0.5362596433152421
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00806452	0.5362596433152421
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00806452	0.5362596433152421
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00806452	0.5362596433152421
JOUBERT SYNDROME 31; JBTS31	0.008029262	0.5339151215701154
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.008029262	0.5339151215701154
JOUBERT SYNDROME 21	0.008029261999999999	0.5339151215701153
HADZISELIMOVIC SYNDROME	0.008029261999999999	0.5339151215701153
CHROMOSOME 1p35 DELETION SYNDROME	0.008000163000000001	0.531980149698159
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.007969521	0.5299425742453775
CHROMOSOME 16p13.2 DELETION SYNDROME	0.007964953	0.5296388197688973
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.007964953	0.5296388197688973
WEAVER SYNDROME	0.007964953	0.5296388197688973
LISSENCEPHALY, X-LINKED, 1; LISX1	0.007958001	0.5291765384377917
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.007958001	0.5291765384377917
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.007958001	0.5291765384377917
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.007958001	0.5291765384377917
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.007948033	0.5285137046765057
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00791631	0.5264042468705991
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00791631	0.5264042468705991
FRONTOOCULAR SYNDROME	0.007897652000000002	0.5251635614454312
HYPERTRYPTOPHANEMIA; HYPTRP	0.007897652000000002	0.5251635614454312
BARDET-BIEDL SYNDROME 1; BBS1	0.007897652000000002	0.5251635614454312
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.007886132	0.5243975256378454
CURRY-JONES SYNDROME	0.007886132	0.5243975256378454
CRANIOTELENCEPHALIC DYSPLASIA	0.007886132	0.5243975256378454
SEPTOOPTIC DYSPLASIA	0.007886132	0.5243975256378454
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.007886132	0.5243975256378454
HOLOPROSENCEPHALY 11	0.007886132	0.5243975256378454
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007886132	0.5243975256378454
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.007883553	0.5242260320312686
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.007831423	0.5207595870096153
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.007831423	0.5207595870096153
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.007831423	0.5207595870096153
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.007831423	0.5207595870096153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007831423	0.5207595870096153
RHYNS SYNDROME; RHYNS	0.0078125	0.5195012801010263
SPONDYLOOCULAR SYNDROME; SOS	0.0078125	0.5195012801010263
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0078125	0.5195012801010263
OSTEOGENESIS IMPERFECTA, TYPE I	0.0078125	0.5195012801010263
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.0078125	0.5195012801010263
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.0078125	0.5195012801010263
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0078125	0.5195012801010263
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.0078125	0.5195012801010263
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0078125	0.5195012801010263
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0078125	0.5195012801010263
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0078125	0.5195012801010263
HYPERPARATHYROIDISM 4	0.0078125	0.5195012801010263
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.0078125	0.5195012801010263
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.0078125	0.5195012801010263
EXUDATIVE VITREORETINOPATHY 4	0.0078125	0.5195012801010263
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0078125	0.5195012801010263
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0078125	0.5195012801010263
GNATHODIAPHYSEAL DYSPLASIA; GDD	0.0078125	0.5195012801010263
OSTEOGENESIS IMPERFECTA, TYPE V	0.0078125	0.5195012801010263
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0078125	0.5195012801010263
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0078125	0.5195012801010263
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.0078125	0.5195012801010263
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0078125	0.5195012801010263
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0078125	0.5195012801010263
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0078125	0.5195012801010263
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.0078125	0.5195012801010263
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0078125	0.5195012801010263
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.0078125	0.5195012801010263
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0078125	0.5195012801010263
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.0078125	0.5195012801010263
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.0078125	0.5195012801010263
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0078125	0.5195012801010263
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0078125	0.5195012801010263
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.0078125	0.5195012801010263
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0078125	0.5195012801010263
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.0078125	0.5195012801010263
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.0078125	0.5195012801010263
BRUCK SYNDROME 2	0.0078125	0.5195012801010263
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.0078125	0.5195012801010263
ESTROGEN RESISTANCE; ESTRR	0.0078125	0.5195012801010263
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0078125	0.5195012801010263
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.0078125	0.5195012801010263
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.0078125	0.5195012801010263
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.0078125	0.5195012801010263
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.007718471	0.513248712310099
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.007718471	0.513248712310099
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.007718471	0.513248712310099
PSEUDO-TORCH SYNDROME 2	0.007647321	0.508517510251963
BARDET-BIEDL SYNDROME 8; BBS8	0.007646602	0.5084696995101526
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007646602	0.5084696995101526
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.007568063	0.5032471572973073
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.007568063	0.5032471572973073
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007568063	0.5032471572973073
NIEMANN-PICK DISEASE, TYPE C2	0.007568063	0.5032471572973073
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.007568063	0.5032471572973073
PELIZAEUS-MERZBACHER DISEASE	0.007568063	0.5032471572973073
MENTAL RETARDATION, X-LINKED 93	0.00756391	0.5029709987288261
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.0074825099999999995	0.49755821099119746
HYPERTELORISM, TEEBI TYPE; TBHS	0.0074825099999999995	0.49755821099119746
DEAFNESS-CRANIOFACIAL SYNDROME	0.0074825099999999995	0.49755821099119746
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0074394330000000005	0.4946937557409048
CHROMOSOME 13q14 DELETION SYNDROME	0.00743038	0.4940917659695442
PHACE ASSOCIATION	0.007377613	0.49058296289151654
DIGEORGE SYNDROME; DGS	0.007377613	0.49058296289151654
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00735412	0.48902076851411963
GAPO SYNDROME; GAPOS	0.0072494610000000004	0.48206134650143573
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0072494610000000004	0.48206134650143573
FRONTONASAL DYSPLASIA 2; FND2	0.00722059	0.4801415357548377
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.007185380000000001	0.47780020582557603
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0071824	0.4776020472572942
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.0071824	0.4776020472572942
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0071824	0.4776020472572942
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.0071824	0.4776020472572942
PELGER-HUET ANOMALY; PHA	0.007177592	0.4772823337014893
FILIPPI SYNDROME; FLPIS	0.007156281	0.47586523395361946
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.007156281	0.47586523395361946
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.007104151	0.4723987889319662
CHROMOSOME 18P DELETION SYNDROME	0.007084412	0.4710862211536732
OGDEN SYNDROME; OGDNS	0.007084412	0.4710862211536732
OCULOSKELETODENTAL SYNDROME; OCSKD	0.007084412	0.4710862211536732
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.007084412	0.4710862211536732
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.007084412	0.4710862211536732
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.007084412	0.4710862211536732
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.007053770000000001	0.4690486457008918
RETINAL CONE DYSTROPHY 3B	0.007053770000000001	0.4690486457008918
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.007053770000000001	0.4690486457008918
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.007053770000000001	0.4690486457008918
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.007053770000000001	0.4690486457008918
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.007053770000000001	0.4690486457008918
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.007053770000000001	0.4690486457008918
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.007053770000000001	0.4690486457008918
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.007053770000000001	0.4690486457008918
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.007053770000000001	0.4690486457008918
ALAGILLE SYNDROME 1; ALGS1	0.007053770000000001	0.4690486457008918
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.007053770000000001	0.4690486457008918
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.007053770000000001	0.4690486457008918
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007049202	0.4687448912244115
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00704225	0.4682826098933059
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00704225	0.4682826098933059
AGNATHIA-OTOCEPHALY COMPLEX	0.00704225	0.4682826098933059
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00704225	0.4682826098933059
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00704225	0.4682826098933059
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00704225	0.4682826098933059
MICROHYDRANENCEPHALY; MHAC	0.00704225	0.4682826098933059
SCHIZENCEPHALY	0.00704225	0.4682826098933059
HYDROLETHALUS SYNDROME 1	0.00704225	0.4682826098933059
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00704225	0.4682826098933059
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00704225	0.4682826098933059
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.4682826098933059
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.00704225	0.4682826098933059
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00704225	0.4682826098933059
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.4682826098933059
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.006987541	0.4646446712650759
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.006987541	0.4646446712650759
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.006987541	0.4646446712650759
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.006967802	0.46333210348678294
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.006915672	0.45986565846512956
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.0069156719999999994	0.4598656584651295
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0069156719999999994	0.4598656584651295
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.00680272	0.4523547837656133
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00680272	0.4523547837656133
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00680272	0.4523547837656133
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00680272	0.4523547837656133
#614416 RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES;RHFCA	0.00680272	0.4523547837656133
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00680272	0.4523547837656133
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00680272	0.4523547837656133
ACHARD SYNDROME	0.00680272	0.4523547837656133
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00680272	0.4523547837656133
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00673157	0.4476235817074772
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.006724180999999999	0.4471322415527678
INFANTILE LIVER FAILURE SYNDROME 1	0.006719373	0.44681252799696297
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.006719373	0.44681252799696297
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.006719373	0.44681252799696297
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.006719373	0.44681252799696297
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006719373	0.44681252799696297
COHEN SYNDROME	0.006595551000000001	0.4385788399963654
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.006533731	0.4344680471469771
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.006533731	0.4344680471469771
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.006533731	0.4344680471469771
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.006523682	0.43379982719641896
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.006523682	0.43379982719641896
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.006509583	0.4328622977822565
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.006509583	0.4328622977822565
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.006509583	0.4328622977822565
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006509583	0.4328622977822565
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.006461862	0.4296890343470307
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.006461862	0.4296890343470307
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.006461862	0.4296890343470307
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.006457453	0.4293958527606032
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.006457453	0.4293958527606032
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.006457453	0.4293958527606032
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.006457453	0.4293958527606032
XQ25 DUPLICATION SYNDROME	0.006457453	0.4293958527606032
PEHO SYNDROME; PEHO	0.006457453	0.4293958527606032
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.006457453	0.4293958527606032
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.006457453	0.4293958527606032
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.006457453	0.4293958527606032
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.006457453	0.4293958527606032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.006457453	0.4293958527606032
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.006457453	0.4293958527606032
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.006457453	0.4293958527606032
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.006457453	0.4293958527606032
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.006454473	0.4291976941923214
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.006454473	0.4291976941923214
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.006454473	0.4291976941923214
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.006454473	0.4291976941923214
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.006454473	0.4291976941923214
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.006454473	0.4291976941923214
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.006454473	0.4291976941923214
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.006454473	0.4291976941923214
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.006454473	0.4291976941923214
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.006454473	0.4291976941923214
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.006454473	0.4291976941923214
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00645032	0.4289215356238402
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00645032	0.4289215356238402
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00645032	0.4289215356238402
CHROMOSOME 17q12 DELETION SYNDROME	0.00645032	0.4289215356238402
#150250 LARSEN SYNDROME; LRS	0.00645032	0.4289215356238402
OMODYSPLASIA	0.00645032	0.4289215356238402
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00633371	0.42116741795694995
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.006325843	0.42064429263591896
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.006240529999999999	0.41497130540913374
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.006240529999999999	0.41497130540913374
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.006240529999999999	0.41497130540913374
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.006240529999999999	0.41497130540913374
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00620532	0.41262997547987207
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00620532	0.41262997547987207
JOHANSON-BLIZZARD SYNDROME; JBS	0.00620532	0.41262997547987207
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00612392	0.40721718774224347
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00612392	0.40721718774224347
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00612392	0.40721718774224347
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00612392	0.40721718774224347
COCKAYNE SYNDROME A; CSA	0.006007481	0.399474440919372
SECKEL SYNDROME 1; SCKL1	0.006007481	0.399474440919372
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.006007481	0.399474440919372
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.005935612	0.3946954281194256
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.005935612	0.3946954281194256
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00580843	0.38623831300828215
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00580843	0.38623831300828215
SPINOCEREBELLAR ATAXIA 1	0.00580843	0.38623831300828215
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00580843	0.38623831300828215
MYOTONIC DYSTROPHY 1	0.00580843	0.38623831300828215
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00580843	0.38623831300828215
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00580843	0.38623831300828215
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00580843	0.38623831300828215
LESCH-NYHAN SYNDROME; LNS	0.00580843	0.38623831300828215
ADDUCTED THUMBS SYNDROME	0.00580843	0.38623831300828215
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0058036220000000005	0.38591859945247725
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.0058036220000000005	0.38591859945247725
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0058036220000000005	0.38591859945247725
JOUBERT SYNDROME 26	0.0058036220000000005	0.38591859945247725
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0058036220000000005	0.38591859945247725
CHROMOSOME 4q21 DELETION SYNDROME	0.0058036220000000005	0.38591859945247725
JOUBERT SYNDROME 32; JBTS32	0.0058036220000000005	0.38591859945247725
HYPOTONIA-CYSTINURIA SYNDROME	0.0058036220000000005	0.38591859945247725
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0056798000000000005	0.3776849114518796
DESBUQUOIS DYSPLASIA 1	0.0056798000000000005	0.3776849114518796
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0056798000000000005	0.3776849114518796
EHLERS-DANLOS SYNDROME, TYPE VI	0.0056798000000000005	0.3776849114518796
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.005665701	0.3767473820377171
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.005665701	0.3767473820377171
LATHOSTEROLOSIS	0.005665701	0.3767473820377171
SPINOCEREBELLAR ATAXIA 47; SCA47	0.005665701	0.3767473820377171
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.005665701	0.3767473820377171
#614432 VENTRICULAR SEPTAL DEFECT 3; VSD3	0.00561798	0.37357411860249135
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00561798	0.37357411860249135
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00561798	0.37357411860249135
LEFT VENTRICULAR NONCOMPACTION 1; LVNC1	0.00561798	0.37357411860249135
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00561798	0.37357411860249135
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.00561798	0.37357411860249135
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.00561798	0.37357411860249135
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00561798	0.37357411860249135
PATENT DUCTUS ARTERIOSUS 3	0.00561798	0.37357411860249135
HOLT-ORAM SYNDROME	0.00561798	0.37357411860249135
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.00561798	0.37357411860249135
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00561798	0.37357411860249135
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.00561798	0.37357411860249135
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.00561798	0.37357411860249135
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.00561798	0.37357411860249135
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00561798	0.37357411860249135
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.00561798	0.37357411860249135
3MC SYNDROME 1	0.00561798	0.37357411860249135
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00561798	0.37357411860249135
LOEYS-DIETZ SYNDROME 3; LDS3	0.00561798	0.37357411860249135
HARDIKAR SYNDROME	0.00561798	0.37357411860249135
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00561798	0.37357411860249135
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.00561798	0.37357411860249135
THORACOABDOMINAL SYNDROME	0.00561798	0.37357411860249135
TRANSALDOLASE DEFICIENCY	0.00561798	0.37357411860249135
PATENT DUCTUS ARTERIOSUS 2	0.00561798	0.37357411860249135
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00561798	0.37357411860249135
CAYLER CARDIOFACIAL SYNDROME	0.00561798	0.37357411860249135
DIAMOND-BLACKFAN ANEMIA 10	0.00561798	0.37357411860249135
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00561798	0.37357411860249135
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.00561798	0.37357411860249135
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00561798	0.37357411860249135
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00561798	0.37357411860249135
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00561798	0.37357411860249135
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00561798	0.37357411860249135
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.00561798	0.37357411860249135
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.00561798	0.37357411860249135
PATENT DUCTUS ARTERIOSUS 1	0.00561798	0.37357411860249135
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.005613571	0.3732809370160638
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.005613571	0.3732809370160638
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.005613571	0.3732809370160638
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.005613571	0.3732809370160638
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.005613571	0.3732809370160638
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.005613571	0.3732809370160638
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.005613571	0.3732809370160638
MENTAL RETARDATION, X-LINKED 102	0.0056135709999999995	0.37328093701606374
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0056135709999999995	0.37328093701606374
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0056135709999999995	0.37328093701606374
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0056135709999999995	0.37328093701606374
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.0056135709999999995	0.37328093701606374
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0056135709999999995	0.37328093701606374
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.005610591	0.37308277844778204
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.005610591	0.37308277844778204
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.005610591	0.37308277844778204
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.005610591	0.37308277844778204
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.005610591	0.37308277844778204
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.005610591	0.37308277844778204
ALZHEIMER DISEASE 3; AD	0.005610591	0.37308277844778204
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.005610591	0.37308277844778204
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.005610591	0.37308277844778204
GLASS SYNDROME	0.005605783	0.37276306489197714
WAISMAN SYNDROME; WSMN	0.005605783	0.37276306489197714
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.005593832	0.37196836923777077
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.005593832	0.37196836923777077
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.005593832	0.37196836923777077
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.005541702	0.3685019242161175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.005541702	0.3685019242161175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.005541702	0.3685019242161175
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.005541702	0.3685019242161175
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.005541702	0.3685019242161175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.005541702	0.3685019242161175
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.005541702	0.3685019242161175
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.005541702	0.3685019242161175
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.005541702	0.3685019242161175
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.005538721999999999	0.3683037656478357
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.005538721999999999	0.3683037656478357
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.005538721999999999	0.3683037656478357
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.005538721999999999	0.3683037656478357
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.005538721999999999	0.3683037656478357
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0054819610000000005	0.3645293768913795
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0054773930000000005	0.3642256224148993
Glycosylphosphatidylinositol biosynthesis defect 18	0.0054773930000000005	0.3642256224148993
MEND SYNDROME; MEND	0.0054773930000000005	0.3642256224148993
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0054773930000000005	0.3642256224148993
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0054773930000000005	0.3642256224148993
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.005477393	0.36422562241489925
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.005477393	0.36422562241489925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.005477393	0.36422562241489925
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.005477393	0.36422562241489925
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.005410092	0.3597503640914332
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.005410092	0.3597503640914332
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.005410092	0.3597503640914332
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.005395993	0.35881283467727065
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.005395993	0.35881283467727065
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.005395993	0.35881283467727065
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.005395993	0.35881283467727065
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005395993	0.35881283467727065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005360783	0.356471504748009
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.005360783	0.356471504748009
MENTAL RETARDATION, X-LINKED 90	0.005360783	0.356471504748009
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.005360783	0.356471504748009
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005360783	0.356471504748009
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005360783	0.356471504748009
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.005360783	0.356471504748009
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005360783	0.356471504748009
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.005360783	0.356471504748009
RAYNAUD-CLAES SYNDROME; MRXSRC	0.005360783	0.356471504748009
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005360783	0.356471504748009
ADAMS-OLIVER SYNDROME 2; AOS2	0.005360783	0.356471504748009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005360783	0.356471504748009
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005360783	0.356471504748009
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.005360783	0.356471504748009
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005360783	0.356471504748009
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.005360783	0.356471504748009
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.005360783	0.356471504748009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005360783	0.356471504748009
LEIGH SYNDROME; LS	0.005360783	0.356471504748009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.005360783	0.356471504748009
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005343863	0.3553463896556174
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.005343863	0.3553463896556174
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005343863	0.3553463896556174
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.005343863	0.3553463896556174
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.005343863	0.3553463896556174
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.005343863	0.3553463896556174
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.005343863	0.3553463896556174
COFFIN-SIRIS SYNDROME 5	0.005343863	0.3553463896556174
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.005343863	0.3553463896556174
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.005343863	0.3553463896556174
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.005343863	0.3553463896556174
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.005343863	0.3553463896556174
LISSENCEPHALY 8; LIS8	0.005343863	0.3553463896556174
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.005343863	0.3553463896556174
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.005343863	0.3553463896556174
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005343863	0.3553463896556174
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.005343863	0.3553463896556174
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005343863	0.3553463896556174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.005343863	0.3553463896556174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.005343863	0.3553463896556174
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00509173	0.33858051237488623
FLOATING-HARBOR SYNDROME	0.00509173	0.33858051237488623
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00509173	0.33858051237488623
SECKEL SYNDROME 5; SCKL5	0.00509173	0.33858051237488623
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00495974	0.3298036837079378
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00495974	0.3298036837079378
OPSISMODYSPLASIA; OPSMD	0.00495974	0.3298036837079378
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00495974	0.3298036837079378
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00495974	0.3298036837079378
MECKEL SYNDROME, TYPE 10; MKS10	0.004761901	0.31664814914743766
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.004761901	0.31664814914743766
HYPOPHOSPHATASIA, CHILDHOOD	0.004761901	0.31664814914743766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.004761901	0.31664814914743766
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.004761901	0.31664814914743766
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00474995	0.31585345349323135
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00474995	0.31585345349323135
SHPRINTZEN OMPHALOCELE SYNDROME	0.00474995	0.31585345349323135
JOUBERT SYNDROME 3; JBTS3	0.00474995	0.31585345349323135
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00474995	0.31585345349323135
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00474995	0.31585345349323135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00469782	0.312387008471578
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00469782	0.312387008471578
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00469782	0.312387008471578
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00469782	0.312387008471578
COMBINED SAPOSIN DEFICIENCY	0.00469782	0.312387008471578
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00469782	0.312387008471578
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00469782	0.312387008471578
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00469782	0.312387008471578
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00469484	0.31218884990329626
NEMALINE MYOPATHY 1; NEM1	0.00469484	0.31218884990329626
WILSON DISEASE	0.00469484	0.31218884990329626
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.00469484	0.31218884990329626
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00469484	0.31218884990329626
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00469484	0.31218884990329626
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00469484	0.31218884990329626
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00469484	0.31218884990329626
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00469484	0.31218884990329626
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.00469484	0.31218884990329626
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.00469484	0.31218884990329626
INCLUSION BODY MYOSITIS	0.00469484	0.31218884990329626
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00469484	0.31218884990329626
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00469484	0.31218884990329626
ODONTOMA-DYSPHAGIA SYNDROME	0.00469484	0.31218884990329626
#614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	0.00469484	0.31218884990329626
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.00469484	0.31218884990329626
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.00469484	0.31218884990329626
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00469484	0.31218884990329626
VISCERAL MYOPATHY; VSCM	0.00469484	0.31218884990329626
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00469484	0.31218884990329626
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00469484	0.31218884990329626
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00469484	0.31218884990329626
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00469484	0.31218884990329626
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00469484	0.31218884990329626
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00469484	0.31218884990329626
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00469484	0.31218884990329626
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.00469484	0.31218884990329626
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.00469484	0.31218884990329626
#615348 NEMALINE MYOPATHY 8; NEM8	0.00469484	0.31218884990329626
ESOPHAGEAL RING, LOWER	0.00469484	0.31218884990329626
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00469484	0.31218884990329626
CHIARI MALFORMATION TYPE I	0.00469484	0.31218884990329626
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00469484	0.31218884990329626
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.00469484	0.31218884990329626
#613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	0.00469484	0.31218884990329626
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.00469484	0.31218884990329626
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.00469484	0.31218884990329626
NEMALINE MYOPATHY 2; NEM2	0.00469484	0.31218884990329626
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00469484	0.31218884990329626
MAST SYNDROME	0.00469484	0.31218884990329626
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00469484	0.31218884990329626
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00469484	0.31218884990329626
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00469484	0.31218884990329626
NEMALINE MYOPATHY 3; NEM3	0.00469484	0.31218884990329626
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00469484	0.31218884990329626
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00469484	0.31218884990329626
MYOPATHY, SPHEROID BODY	0.00469484	0.31218884990329626
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00469484	0.31218884990329626
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00469484	0.31218884990329626
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00469484	0.31218884990329626
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.00469484	0.31218884990329626
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00469484	0.31218884990329626
#118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1;;PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;;CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;;MOUNT-REBACK SYNDROME;;CHOREOATHETOSIS, NONKINESIGENIC;;DYSTONIA 8; DYT8	0.00469484	0.31218884990329626
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00469484	0.31218884990329626
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00469484	0.31218884990329626
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00469484	0.31218884990329626
DYSTONIA 16; DYT16	0.00469484	0.31218884990329626
IMMUNODEFICIENCY 58; IMD58	0.00469484	0.31218884990329626
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.00469484	0.31218884990329626
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00469484	0.31218884990329626
PRIMARY LATERAL SCLEROSIS, ADULT	0.00469484	0.31218884990329626
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00469484	0.31218884990329626
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA 14	0.00469484	0.31218884990329626
DYSTONIA 12; DYT12	0.00469484	0.31218884990329626
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00469484	0.31218884990329626
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00469484	0.31218884990329626
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00469484	0.31218884990329626
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00469484	0.31218884990329626
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00469484	0.31218884990329626
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00469484	0.31218884990329626
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00469484	0.31218884990329626
LARYNGEAL ABDUCTOR PARALYSIS	0.00469484	0.31218884990329626
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.00469484	0.31218884990329626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00469484	0.31218884990329626
PARKINSON DISEASE, LATE-ONSET; PD	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00469484	0.31218884990329626
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00469484	0.31218884990329626
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00469484	0.31218884990329626
SPINOCEREBELLAR ATAXIA 42	0.00469484	0.31218884990329626
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00469484	0.31218884990329626
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00469484	0.31218884990329626
#610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	0.00469484	0.31218884990329626
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00469484	0.31218884990329626
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.00469484	0.31218884990329626
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00469484	0.31218884990329626
LEBER OPTIC ATROPHY AND DYSTONIA	0.00469484	0.31218884990329626
MACHADO-JOSEPH DISEASE; MJD	0.00469484	0.31218884990329626
MYASTHENIA GRAVIS; MG	0.00469484	0.31218884990329626
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.00469484	0.31218884990329626
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00469484	0.31218884990329626
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.00469484	0.31218884990329626
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00469484	0.31218884990329626
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00469484	0.31218884990329626
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00469484	0.31218884990329626
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00469484	0.31218884990329626
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00469484	0.31218884990329626
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.004690032	0.3118691363474914
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004690032	0.3118691363474914
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004690032	0.3118691363474914
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.004690032	0.3118691363474914
THANATOPHORIC DYSPLASIA, TYPE I	0.004690032	0.3118691363474914
MACROCEPHALY/AUTISM SYNDROME	0.004690032	0.3118691363474914
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.004690032	0.3118691363474914
FORSYTHE-WAKELING SYNDROME; FWS	0.004690032	0.3118691363474914
Retinitis pigmentosa with or without skeletal anomalies	0.004690032	0.3118691363474914
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.004633511	0.30811070667035984
BRITTLE CORNEA SYNDROME	0.00456621	0.30363544834689377
MUCOLIPIDOSIS III GAMMA	0.00456621	0.30363544834689377
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00456621	0.30363544834689377
%609259 MYOPIA 10; MYP10	0.00456621	0.30363544834689377
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00456621	0.30363544834689377
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00456621	0.30363544834689377
ALAND ISLAND EYE DISEASE	0.00456621	0.30363544834689377
%310460 MYOPIA 1, X-LINKED; MYP1	0.00456621	0.30363544834689377
#312600 RETINITIS PIGMENTOSA 2; RP2	0.00456621	0.30363544834689377
GLAUCOMA, PRIMARY OPEN ANGLE	0.00456621	0.30363544834689377
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00456621	0.30363544834689377
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00456621	0.30363544834689377
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00456621	0.30363544834689377
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00456621	0.30363544834689377
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00456621	0.30363544834689377
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00456621	0.30363544834689377
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00456621	0.30363544834689377
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00456621	0.30363544834689377
EHLERS-DANLOS SYNDROME, TYPE I	0.00456621	0.30363544834689377
#615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	0.00456621	0.30363544834689377
STICKLER SYNDROME, TYPE II	0.00456621	0.30363544834689377
MICROSPHEROPHAKIA WITH HERNIA	0.00456621	0.30363544834689377
GLAUCOMA 1, OPEN ANGLE, A	0.00456621	0.30363544834689377
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.00456621	0.30363544834689377
#156550 KNIEST DYSPLASIA	0.00456621	0.30363544834689377
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00456621	0.30363544834689377
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00456621	0.30363544834689377
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00456621	0.30363544834689377
#115900 CATARACT 42; CTRCT42	0.00456621	0.30363544834689377
BLUE CONE MONOCHROMACY; BCM	0.00456621	0.30363544834689377
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00456621	0.30363544834689377
VAN BOGAERT-HOZAY SYNDROME	0.00456621	0.30363544834689377
RETINITIS PIGMENTOSA 75; RP75	0.00456621	0.30363544834689377
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00456621	0.30363544834689377
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00456621	0.30363544834689377
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00456621	0.30363544834689377
MYOPIA 15; MYP15	0.00456621	0.30363544834689377
%609256 MYOPIA 7; MYP7	0.00456621	0.30363544834689377
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00456621	0.30363544834689377
MICROCORIA, CONGENITAL	0.00456621	0.30363544834689377
%609257 MYOPIA 8; MYP8	0.00456621	0.30363544834689377
SVEINSSON CHORIORETINAL ATROPHY	0.00456621	0.30363544834689377
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00456621	0.30363544834689377
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00456621	0.30363544834689377
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00456621	0.30363544834689377
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00456621	0.30363544834689377
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00456621	0.30363544834689377
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00456621	0.30363544834689377
%609258 MYOPIA 9; MYP9	0.00456621	0.30363544834689377
#310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A;;CSNB, COMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA;;HEMERALOPIA-MYOPIA;;MYOPIA-NIGHT BLINDNESS; NBM1NYCTALOPIA, INCLUDED	0.00456621	0.30363544834689377
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00456621	0.30363544834689377
MYOPIA, INFANTILE SEVERE	0.00456621	0.30363544834689377
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00456621	0.30363544834689377
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00456621	0.30363544834689377
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.00456621	0.30363544834689377
BARDET-BIEDL SYNDROME 21; BBS21	0.00456621	0.30363544834689377
ALPORT SYNDROME, X-LINKED; ATS	0.00456621	0.30363544834689377
#257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B;;NIGHT BLINDNESS, CONGENITAL STATIONARY, COMPLETE, AUTOSOMAL RECESSIVE;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00456621	0.30363544834689377
WEILL-MARCHESANI SYNDROME 3	0.00456621	0.30363544834689377
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00456621	0.30363544834689377
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00456621	0.30363544834689377
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00456621	0.30363544834689377
STICKLER SYNDROME, TYPE I	0.00456621	0.30363544834689377
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00456621	0.30363544834689377
GASTROCUTANEOUS SYNDROME	0.00456621	0.30363544834689377
#608908 MYOPIA 6; MYP6	0.00456621	0.30363544834689377
#609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR;;STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;;STICKLER SYNDROME, ATYPICALRHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD,INCLUDED	0.00456621	0.30363544834689377
RETINITIS PIGMENTOSA 1	0.00456621	0.30363544834689377
BRITTLE CORNEA SYNDROME 2; BCS2	0.00456621	0.30363544834689377
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00456621	0.30363544834689377
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00456621	0.30363544834689377
AU-KLINE SYNDROME; AUKS	0.004561642	0.30333169387041353
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.004561642	0.30333169387041353
CYCLIC VOMITING SYNDROME	0.004516901	0.30035658900346957
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004516901	0.30035658900346957
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.004516901	0.30035658900346957
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004499981	0.29923147391107796
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004499981	0.29923147391107796
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.004499981	0.29923147391107796
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.004499981	0.29923147391107796
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004499981	0.29923147391107796
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.004499981	0.29923147391107796
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.004499981	0.29923147391107796
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.004499981	0.29923147391107796
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004499981	0.29923147391107796
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.004499981	0.29923147391107796
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.004480242	0.29791890613278493
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.004480242	0.29791890613278493
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.004480242	0.29791890613278493
STEEL SYNDROME; STLS	0.004480242	0.29791890613278493
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004480242	0.29791890613278493
ALAZAMI SYNDROME; ALAZS	0.004480242	0.29791890613278493
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004480242	0.29791890613278493
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.004445032000000001	0.29557757620352326
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004445032000000001	0.29557757620352326
JOUBERT SYNDROME 14	0.004445032000000001	0.29557757620352326
MARINESCO-SJOGREN SYNDROME; MSS	0.004445032000000001	0.29557757620352326
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.004445032000000001	0.29557757620352326
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.004445032000000001	0.29557757620352326
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004445032000000001	0.29557757620352326
MUCOLIPIDOSIS IV; ML4	0.004445032000000001	0.29557757620352326
COFFIN-SIRIS SYNDROME 7; CSS7	0.004445032000000001	0.29557757620352326
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.004445032000000001	0.29557757620352326
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.004428112	0.2944524611111316
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004428112	0.2944524611111316
PEHO-LIKE SYNDROME; PEHOL	0.004428112	0.2944524611111316
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.004428112	0.2944524611111316
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.004428112	0.2944524611111316
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004428112	0.2944524611111316
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.004428112	0.2944524611111316
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.004428112	0.2944524611111316
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.004428112	0.2944524611111316
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.004428112	0.2944524611111316
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.004428112	0.2944524611111316
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.004428112	0.2944524611111316
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.004428112	0.2944524611111316
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.004363803	0.2901761593099135
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.004363803	0.2901761593099135
CATEL-MANZKE SYNDROME; CATMANS	0.004363803	0.2901761593099135
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004363803	0.2901761593099135
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.004363802999999999	0.2901761593099134
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.004363802999999999	0.2901761593099134
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.004363802999999999	0.2901761593099134
MENTAL RETARDATION, X-LINKED 103	0.004363802999999999	0.2901761593099134
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.004247193	0.2824220416430231
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004247193	0.2824220416430231
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.004247193	0.2824220416430231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.004247193	0.2824220416430231
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004247193	0.2824220416430231
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004247193	0.2824220416430231
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.004247193	0.2824220416430231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.004247193	0.2824220416430231
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00384615	0.255754220602952
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00384615	0.255754220602952
MEESTER-LOEYS SYNDROME; MRLS	0.00384615	0.255754220602952
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00384615	0.255754220602952
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00384615	0.255754220602952
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00384615	0.255754220602952
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00384615	0.255754220602952
TRICHODENTOOSSEOUS SYNDROME	0.00384615	0.255754220602952
CLEIDOCRANIAL DYSPLASIA; CCD	0.00384615	0.255754220602952
MACROCEPHALY, BENIGN FAMILIAL	0.00384615	0.255754220602952
SCHIZOPHRENIA 1; SCZD1	0.00384615	0.255754220602952
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00384615	0.255754220602952
SCLEROSTEOSIS 2; SOST2	0.00384615	0.255754220602952
CRANIOECTODERMAL DYSPLASIA 4	0.00384615	0.255754220602952
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00384615	0.255754220602952
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00384615	0.255754220602952
268650 RUDIGER SYNDROME	0.00384615	0.255754220602952
#100800 ACHONDROPLASIA; ACH	0.00384615	0.255754220602952
TRICHOHEPATOENTERIC SYNDROME 1	0.00384615	0.255754220602952
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00384615	0.255754220602952
HYPOCHONDROPLASIA	0.00384615	0.255754220602952
FIBROCHONDROGENESIS 1; FBCG1	0.00384615	0.255754220602952
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.00384615	0.255754220602952
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.00384615	0.255754220602952
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00384615	0.255754220602952
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00384615	0.255754220602952
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00384615	0.255754220602952
CINCA SYNDROME; CINCA	0.00384615	0.255754220602952
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00384615	0.255754220602952
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.00384615	0.255754220602952
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00384615	0.255754220602952
#300640 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	0.00384615	0.255754220602952
PYCNODYSOSTOSIS	0.00384615	0.255754220602952
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00384615	0.255754220602952
Miller-Dieker syndrome (MDS)	0.00384615	0.255754220602952
NASODIGITOACOUSTIC SYNDROME	0.00384615	0.255754220602952
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00384615	0.255754220602952
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00384615	0.255754220602952
THREE M SYNDROME 2; 3M2	0.00384615	0.255754220602952
RUIJS-AALFS SYNDROME; RJALS	0.00384615	0.255754220602952
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00384615	0.255754220602952
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00384615	0.255754220602952
SIFRIM-HITZ-WEISS SYNDROME	0.0037177599999999996	0.2472167781258741
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0037177599999999996	0.2472167781258741
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.0037177599999999996	0.2472167781258741
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00363636	0.2418039903882455
DIAMOND-BLACKFAN ANEMIA 8	0.00363636	0.2418039903882455
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00363636	0.2418039903882455
600736 VELOFACIOSKELETAL SYNDROME	0.00363636	0.2418039903882455
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.00363636	0.2418039903882455
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00363636	0.2418039903882455
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00363636	0.2418039903882455
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00363636	0.2418039903882455
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00363636	0.2418039903882455
BOOMERANG DYSPLASIA	0.00363636	0.2418039903882455
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00363636	0.2418039903882455
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00363636	0.2418039903882455
ZECHI-CEIDE SYNDROME	0.00363636	0.2418039903882455
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00363636	0.2418039903882455
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00363636	0.2418039903882455
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00363636	0.2418039903882455
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00363636	0.2418039903882455
608028 THAI SYMPHALANGISM SYNDROME	0.00363636	0.2418039903882455
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00363636	0.2418039903882455
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00363636	0.2418039903882455
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00363636	0.2418039903882455
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00363636	0.2418039903882455
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00363636	0.2418039903882455
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.00363636	0.2418039903882455
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00363636	0.2418039903882455
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00363636	0.2418039903882455
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00363636	0.2418039903882455
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00363636	0.2418039903882455
FRONTOMETAPHYSEAL DYSPLASIA	0.00363636	0.2418039903882455
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00360115	0.2394626604589838
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00360115	0.2394626604589838
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00360115	0.2394626604589838
SOTOS SYNDROME 2	0.00360115	0.2394626604589838
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00358423	0.23833754536659219
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00358423	0.23833754536659219
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.00358423	0.23833754536659219
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00358423	0.23833754536659219
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00358423	0.23833754536659219
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00358423	0.23833754536659219
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00358423	0.23833754536659219
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00358423	0.23833754536659219
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00358423	0.23833754536659219
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00358423	0.23833754536659219
ANIRIDIA	0.00358423	0.23833754536659219
MECKEL SYNDROME, TYPE 4; MKS4	0.00358423	0.23833754536659219
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00358423	0.23833754536659219
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00358423	0.23833754536659219
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00358423	0.23833754536659219
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00358423	0.23833754536659219
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0035199209999999996	0.23406124356537397
224250 DYSMYELINATION WITH JAUNDICE	0.0035199209999999996	0.23406124356537397
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.0035199209999999996	0.23406124356537397
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.0035199209999999996	0.23406124356537397
RETINITIS PIGMENTOSA 59; RP59	0.0035199209999999996	0.23406124356537397
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0035199209999999996	0.23406124356537397
ALAZAMI-YUAN SYNDROME	0.003448052	0.2292822307654277
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.003448052	0.2292822307654277
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.003448052	0.2292822307654277
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.003448052	0.2292822307654277
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003448052	0.2292822307654277
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.003448052	0.2292822307654277
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.003448052	0.2292822307654277
LIG4 SYNDROME	0.003448052	0.2292822307654277
CHROMOSOME 15q25 DELETION SYNDROME	0.003448052	0.2292822307654277
NOONAN SYNDROME 9; NS9	0.003448052	0.2292822307654277
NOONAN SYNDROME 5; NS5	0.003448052	0.2292822307654277
CULLER-JONES SYNDROME; CJS	0.003448052	0.2292822307654277
MENTAL RETARDATION, X-LINKED 106; MRX106	0.003448052	0.2292822307654277
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.003448052	0.2292822307654277
NOONAN SYNDROME 2; NS2	0.003448052	0.2292822307654277
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.003448052	0.2292822307654277
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.003403311	0.22630712589848367
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.003403311	0.22630712589848367
GAUCHER DISEASE, TYPE IIIC	0.003403311	0.22630712589848367
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.003403311	0.22630712589848367
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.003403311	0.22630712589848367
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.003403311	0.22630712589848367
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.003403311	0.22630712589848367
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.003403311	0.22630712589848367
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.003403311	0.22630712589848367
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0033314420000000004	0.2215281130985374
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0033314420000000004	0.2215281130985374
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0033314420000000004	0.2215281130985374
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0033314420000000004	0.2215281130985374
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0033314420000000004	0.2215281130985374
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.0033314420000000004	0.2215281130985374
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0033314420000000004	0.2215281130985374
SENIOR-LOKEN SYNDROME 9	0.0033314420000000004	0.2215281130985374
NEPHRONOPHTHISIS 11; NPHP11	0.0033314420000000004	0.2215281130985374
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0033314420000000004	0.2215281130985374
RICHARDS-RUNDLE SYNDROME; RRNS	0.0033314420000000004	0.2215281130985374
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0033314420000000004	0.2215281130985374
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0028732230000000003	0.19105830739401103
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0028732230000000003	0.19105830739401103
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0028732230000000003	0.19105830739401103
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0028732230000000003	0.19105830739401103
SHUKLA-VERNON SYNDROME; SHUVER	0.0028732230000000003	0.19105830739401103
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0028732230000000003	0.19105830739401103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0028732230000000003	0.19105830739401103
LUSCAN-LUMISH SYNDROME; LLS	0.0028732230000000003	0.19105830739401103
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0028732230000000003	0.19105830739401103
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0028732230000000003	0.19105830739401103
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0028732230000000003	0.19105830739401103
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0028732230000000003	0.19105830739401103
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0028732230000000003	0.19105830739401103
HYPERPROLINEMIA, TYPE I	0.0028732230000000003	0.19105830739401103
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0028732230000000003	0.19105830739401103
WIEACKER-WOLFF SYNDROME	0.0028732230000000003	0.19105830739401103
SALLA DISEASE	0.0028732230000000003	0.19105830739401103
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028732230000000003	0.19105830739401103
KETOADIPICACIDURIA	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0028732230000000003	0.19105830739401103
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0028732230000000003	0.19105830739401103
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0028732230000000003	0.19105830739401103
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0028732230000000003	0.19105830739401103
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0028732230000000003	0.19105830739401103
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0028732230000000003	0.19105830739401103
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0028732230000000003	0.19105830739401103
PETTIGREW SYNDROME	0.0028732230000000003	0.19105830739401103
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0028732230000000003	0.19105830739401103
PYRUVATE CARBOXYLASE DEFICIENCY	0.0028732230000000003	0.19105830739401103
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0028732230000000003	0.19105830739401103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0028732230000000003	0.19105830739401103
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0028732230000000003	0.19105830739401103
COACH SYNDROME	0.0028732230000000003	0.19105830739401103
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0028732230000000003	0.19105830739401103
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0028732230000000003	0.19105830739401103
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0028732230000000003	0.19105830739401103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0028732230000000003	0.19105830739401103
FOLATE MALABSORPTION, HEREDITARY	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0028732230000000003	0.19105830739401103
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0028732230000000003	0.19105830739401103
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0028732230000000003	0.19105830739401103
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0028732230000000003	0.19105830739401103
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0028732230000000003	0.19105830739401103
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0028732230000000003	0.19105830739401103
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0028732230000000003	0.19105830739401103
IMMUNODEFICIENCY 49; IMD49	0.0028732230000000003	0.19105830739401103
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0028732230000000003	0.19105830739401103
ELEJALDE DISEASE	0.0028732230000000003	0.19105830739401103
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0028732230000000003	0.19105830739401103
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0028732230000000003	0.19105830739401103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0028732230000000003	0.19105830739401103
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0028732230000000003	0.19105830739401103
SULFOCYSTEINURIA	0.0028732230000000003	0.19105830739401103
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0028732230000000003	0.19105830739401103
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0028732230000000003	0.19105830739401103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.0028732230000000003	0.19105830739401103
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0028732230000000003	0.19105830739401103
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0028732230000000003	0.19105830739401103
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0028732230000000003	0.19105830739401103
JOUBERT SYNDROME 30; JBTS30	0.0028732230000000003	0.19105830739401103
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0028732230000000003	0.19105830739401103
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.0028732230000000003	0.19105830739401103
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0028732230000000003	0.19105830739401103
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0028732230000000003	0.19105830739401103
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0028732230000000003	0.19105830739401103
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.0028732230000000003	0.19105830739401103
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0028732230000000003	0.19105830739401103
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0028732230000000003	0.19105830739401103
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0028732230000000003	0.19105830739401103
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.0028732230000000003	0.19105830739401103
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0028732230000000003	0.19105830739401103
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0028732230000000003	0.19105830739401103
AICARDI-GOUTIERES SYNDROME 7	0.0028732230000000003	0.19105830739401103
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0028732230000000003	0.19105830739401103
GRISCELLI SYNDROME, TYPE 1	0.0028732230000000003	0.19105830739401103
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0028732230000000003	0.19105830739401103
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0028732230000000003	0.19105830739401103
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0028732230000000003	0.19105830739401103
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0028732230000000003	0.19105830739401103
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0028732230000000003	0.19105830739401103
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0028732230000000003	0.19105830739401103
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0028732230000000003	0.19105830739401103
8p23.1 deletion syndrome	0.00260417	0.17316731502088825
ADRENAL HYPOPLASIA, CONGENITAL	0.00260417	0.17316731502088825
UROFACIAL SYNDROME	0.00260417	0.17316731502088825
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00260417	0.17316731502088825
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00260417	0.17316731502088825
#615542 TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD	0.00260417	0.17316731502088825
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00260417	0.17316731502088825
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00260417	0.17316731502088825
ELLIS-VAN CREVELD SYNDROME	0.00260417	0.17316731502088825
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00260417	0.17316731502088825
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00260417	0.17316731502088825
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.00260417	0.17316731502088825
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00260417	0.17316731502088825
OROFACIAL CLEFT 15	0.00260417	0.17316731502088825
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00260417	0.17316731502088825
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00260417	0.17316731502088825
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00260417	0.17316731502088825
NOONAN SYNDROME 4; NS4	0.00260417	0.17316731502088825
RUVALCABA SYNDROME	0.00260417	0.17316731502088825
#614840 HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11	0.00260417	0.17316731502088825
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00260417	0.17316731502088825
WIDOW&#39;S PEAK SYNDROME	0.00260417	0.17316731502088825
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00260417	0.17316731502088825
POPLITEAL PTERYGIUM SYNDROME	0.00260417	0.17316731502088825
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00260417	0.17316731502088825
N SYNDROME	0.00260417	0.17316731502088825
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.00260417	0.17316731502088825
MACS SYNDROME	0.00260417	0.17316731502088825
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00260417	0.17316731502088825
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00260417	0.17316731502088825
BLOOM SYNDROME	0.00260417	0.17316731502088825
BECKWITH-WIEDEMANN SYNDROME	0.00260417	0.17316731502088825
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00260417	0.17316731502088825
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00260417	0.17316731502088825
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00260417	0.17316731502088825
REIFENSTEIN SYNDROME	0.00260417	0.17316731502088825
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00260417	0.17316731502088825
WT LIMB-BLOOD SYNDROME	0.00260417	0.17316731502088825
#614858 HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14	0.00260417	0.17316731502088825
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22	0.00260417	0.17316731502088825
ICHTHYOSIS, X-LINKED	0.00260417	0.17316731502088825
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00260417	0.17316731502088825
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00260417	0.17316731502088825
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00260417	0.17316731502088825
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00260417	0.17316731502088825
BARDET-BIEDL SYNDROME 4; BBS4	0.00260417	0.17316731502088825
Oliver-McFarlane syndrome	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	0.00260417	0.17316731502088825
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.00260417	0.17316731502088825
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00260417	0.17316731502088825
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00260417	0.17316731502088825
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00260417	0.17316731502088825
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00260417	0.17316731502088825
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00260417	0.17316731502088825
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.00260417	0.17316731502088825
VELOCARDIOFACIAL SYNDROME	0.00260417	0.17316731502088825
NOONAN SYNDROME 10; NS10	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00260417	0.17316731502088825
601095 HARROD SYNDROME	0.00260417	0.17316731502088825
TESTICULAR GERM CELL TUMOR; TGCT	0.00260417	0.17316731502088825
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00260417	0.17316731502088825
#614279 46,XY SEX REVERSAL 8; SRXY8;;MALE PSEUDOHERMAPHRODITISM DUE TO DEFICIENCY OF TESTICULAR 17,20-DESMOLASE;TDD	0.00260417	0.17316731502088825
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.00260417	0.17316731502088825
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00248756	0.16541319735399795
VITREORETINOCHOROIDOPATHY; VRCP	0.00248756	0.16541319735399795
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00248756	0.16541319735399795
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00248756	0.16541319735399795
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00248756	0.16541319735399795
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00248756	0.16541319735399795
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00248756	0.16541319735399795
GLUTATHIONURIA	0.00248756	0.16541319735399795
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00248756	0.16541319735399795
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00248756	0.16541319735399795
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00248756	0.16541319735399795
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00248756	0.16541319735399795
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00248756	0.16541319735399795
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00248756	0.16541319735399795
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00248756	0.16541319735399795
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00248756	0.16541319735399795
#608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;;CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB;;REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;;CORNEAL DYSTROPHY, GEOGRAPHIC;;GRANULAR CORNEAL DYSTROPHY, TYPE III	0.00248756	0.16541319735399795
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00248756	0.16541319735399795
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00248756	0.16541319735399795
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00248756	0.16541319735399795
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00248756	0.16541319735399795
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.00248756	0.16541319735399795
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00248756	0.16541319735399795
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00248756	0.16541319735399795
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00248756	0.16541319735399795
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00248756	0.16541319735399795
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00248756	0.16541319735399795
CHANARIN-DORFMAN SYNDROME	0.00248756	0.16541319735399795
NEPHRONOPHTHISIS 18; NPHP18	0.00248756	0.16541319735399795
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00248756	0.16541319735399795
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00248756	0.16541319735399795
PETERS ANOMALY	0.00248756	0.16541319735399795
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.00248756	0.16541319735399795
ABDUCENS PALSY	0.00248756	0.16541319735399795
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00248756	0.16541319735399795
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00248756	0.16541319735399795
LEBER CONGENITAL AMAUROSIS 16	0.00248756	0.16541319735399795
SPASTIC PARAPLEGIA 16, X-LINKED	0.00248756	0.16541319735399795
OPTIC ATROPHY 1; OPA1	0.00248756	0.16541319735399795
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00248756	0.16541319735399795
DUANE-RADIAL RAY SYNDROME; DRRS	0.00248756	0.16541319735399795
IVIC SYNDROME	0.00248756	0.16541319735399795
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00248756	0.16541319735399795
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00248756	0.16541319735399795
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.00248756	0.16541319735399795
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00248756	0.16541319735399795
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00248756	0.16541319735399795
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00248756	0.16541319735399795
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00248756	0.16541319735399795
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00248756	0.16541319735399795
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00248756	0.16541319735399795
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00248756	0.16541319735399795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002029341	0.1349433916494716
SUDDEN CARDIAC FAILURE, INFANTILE	0.002029341	0.1349433916494716
VISCERAL STEATOSIS, CONGENITAL	0.002029341	0.1349433916494716
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002029341	0.1349433916494716
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002029341	0.1349433916494716
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002029341	0.1349433916494716
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.002029341	0.1349433916494716
HYPOPHOSPHATASIA, INFANTILE	0.002029341	0.1349433916494716
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.002029341	0.1349433916494716
COFFIN-SIRIS SYNDROME 8; CSS8	0.002029341	0.1349433916494716
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.002029341	0.1349433916494716
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.002029341	0.1349433916494716
XYLOSIDASE DEFICIENCY	0.002029341	0.1349433916494716
TAY-SACHS DISEASE; TSD	0.002029341	0.1349433916494716
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.002029341	0.1349433916494716
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.002029341	0.1349433916494716
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002029341	0.1349433916494716
EPISODIC ATAXIA, TYPE 6	0.002029341	0.1349433916494716
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002029341	0.1349433916494716
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.002029341	0.1349433916494716
NEURAMINIDASE DEFICIENCY	0.002029341	0.1349433916494716
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002029341	0.1349433916494716
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.002029341	0.1349433916494716
GLUTARIC ACIDEMIA I; GA1	0.002029341	0.1349433916494716
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002029341	0.1349433916494716
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002029341	0.1349433916494716
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.002029341	0.1349433916494716
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.002029341	0.1349433916494716
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002029341	0.1349433916494716
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.002029341	0.1349433916494716
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.002029341	0.1349433916494716
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002029341	0.1349433916494716
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.002029341	0.1349433916494716
MAPLE SYRUP URINE DISEASE; MSUD	0.002029341	0.1349433916494716
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002029341	0.1349433916494716
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002029341	0.1349433916494716
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.002029341	0.1349433916494716
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.002029341	0.1349433916494716
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.002029341	0.1349433916494716
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001957472	0.13016437884952528
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001957472	0.13016437884952528
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.001957472	0.13016437884952528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001957472	0.13016437884952528
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001957472	0.13016437884952528
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001957472	0.13016437884952528
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001957472	0.13016437884952528
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001957472	0.13016437884952528
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001957472	0.13016437884952528
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001957472	0.13016437884952528
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001957472	0.13016437884952528
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001957472	0.13016437884952528
JOUBERT SYNDROME 15	0.001957472	0.13016437884952528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.001957472	0.13016437884952528
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001957472	0.13016437884952528
JOUBERT SYNDROME 25	0.001957472	0.13016437884952528
JOUBERT SYNDROME 8	0.001957472	0.13016437884952528
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.001957472	0.13016437884952528
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001957472	0.13016437884952528
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001957472	0.13016437884952528
NAVAJO NEUROHEPATOPATHY	0.001957472	0.13016437884952528
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001957472	0.13016437884952528
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001957472	0.13016437884952528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001957472	0.13016437884952528
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001957472	0.13016437884952528
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001957472	0.13016437884952528
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001957472	0.13016437884952528
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001957472	0.13016437884952528
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001957472	0.13016437884952528
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001957472	0.13016437884952528
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.001957472	0.13016437884952528
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001957472	0.13016437884952528
PEROXISOME BIOGENESIS DISORDER 5B	0.001957472	0.13016437884952528
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.001957472	0.13016437884952528
NIEMANN-PICK DISEASE, TYPE A	0.001957472	0.13016437884952528
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001957472	0.13016437884952528
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001957472	0.13016437884952528
JOUBERT SYNDROME 27	0.001957472	0.13016437884952528
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.001957472	0.13016437884952528
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.001957472	0.13016437884952528
ARIMA SYNDROME	0.001957472	0.13016437884952528
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001957472	0.13016437884952528
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001957472	0.13016437884952528
WARSAW BREAKAGE SYNDROME; WABS	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.001957472	0.13016437884952528
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001957472	0.13016437884952528
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001957472	0.13016437884952528
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001957472	0.13016437884952528
JOUBERT SYNDROME 1	0.001957472	0.13016437884952528
JOUBERT SYNDROME 24	0.001957472	0.13016437884952528
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001957472	0.13016437884952528
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001957472	0.13016437884952528
IMMUNODEFICIENCY 23; IMD23	0.001957472	0.13016437884952528
JOUBERT SYNDROME 28	0.001957472	0.13016437884952528
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001957472	0.13016437884952528
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001957472	0.13016437884952528
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001957472	0.13016437884952528
PEROXISOME BIOGENESIS DISORDER 3B	0.001957472	0.13016437884952528
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.001957472	0.13016437884952528
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001957472	0.13016437884952528
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001957472	0.13016437884952528
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001957472	0.13016437884952528
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001957472	0.13016437884952528
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.001957472	0.13016437884952528
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.001957472	0.13016437884952528
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001957472	0.13016437884952528
MENTAL RETARDATION, X-LINKED 99	0.001957472	0.13016437884952528
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001957472	0.13016437884952528
GALACTOSE EPIMERASE DEFICIENCY	0.001957472	0.13016437884952528
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001957472	0.13016437884952528
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001957472	0.13016437884952528
PEROXISOME BIOGENESIS DISORDER 10B	0.001957472	0.13016437884952528
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001957472	0.13016437884952528
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.001957472	0.13016437884952528
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001957472	0.13016437884952528
DIAPHANOSPONDYLODYSOSTOSIS	0.001957472	0.13016437884952528
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001957472	0.13016437884952528
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.001957472	0.13016437884952528
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001957472	0.13016437884952528
OROFACIODIGITAL SYNDROME XVI; OFD16	0.001957472	0.13016437884952528
MENTAL RETARDATION, X-LINKED 41	0.001957472	0.13016437884952528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001957472	0.13016437884952528
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001957472	0.13016437884952528
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001957472	0.13016437884952528
NOONAN SYNDROME 11; NS11	0.001957472	0.13016437884952528
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001957472	0.13016437884952528
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.001957472	0.13016437884952528
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001957472	0.13016437884952528
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.001957472	0.13016437884952528
RING CHROMOSOME 14 SYNDROME	0.001957472	0.13016437884952528
AL-RAQAD SYNDROME; ARS	0.001957472	0.13016437884952528
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001957472	0.13016437884952528
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.001957472	0.13016437884952528
JOUBERT SYNDROME 6	0.001957472	0.13016437884952528
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001957472	0.13016437884952528
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001957472	0.13016437884952528
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001957472	0.13016437884952528
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001957472	0.13016437884952528
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.11700884428902517
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.11700884428902517
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.11700884428902517
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.11700884428902517
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.11700884428902517
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.11700884428902517
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.11700884428902517
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.11700884428902517
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.11700884428902517
PROPIONIC ACIDEMIA	0.001759633	0.11700884428902517
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.11700884428902517
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.11700884428902517
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.11700884428902517
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.11700884428902517
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.11700884428902517
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.11700884428902517
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.11700884428902517
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.11700884428902517
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.11700884428902517
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.11700884428902517
HARTNUP DISORDER	0.001759633	0.11700884428902517
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.11700884428902517
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001759633	0.11700884428902517
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.11700884428902517
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.11700884428902517
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.11700884428902517
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.11700884428902517
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.11700884428902517
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.11700884428902517
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.11700884428902517
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.11700884428902517
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001759633	0.11700884428902517
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.11700884428902517
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.001759633	0.11700884428902517
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.11700884428902517
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.11700884428902517
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.11700884428902517
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.11700884428902517
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.11700884428902517
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.11700884428902517
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.11700884428902517
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.11700884428902517
MACDERMOT-WINTER SYNDROME	0.001759633	0.11700884428902517
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.11700884428902517
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.11700884428902517
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001759633	0.11700884428902517
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.11700884428902517
Cerebral creatine deficiency syndrome 2	0.001759633	0.11700884428902517
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.001759633	0.11700884428902517
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.11700884428902517
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.11700884428902517
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.11700884428902517
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.11700884428902517
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.11700884428902517
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.11700884428902517
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.11700884428902517
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.11700884428902517
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.11700884428902517
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.11700884428902517
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.11700884428902517
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.11700884428902517
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.11700884428902517
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.11700884428902517
CITRULLINEMIA, CLASSIC	0.001759633	0.11700884428902517
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.11700884428902517
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.11700884428902517
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.11700884428902517
LANDAU-KLEFFNER SYNDROME	0.001759633	0.11700884428902517
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.11700884428902517
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.001759633	0.11700884428902517
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.11700884428902517
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.11700884428902517
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.11700884428902517
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.11700884428902517
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.11700884428902517
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.11700884428902517
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001759633	0.11700884428902517
ARGININOSUCCINIC ACIDURIA	0.001759633	0.11700884428902517
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.11700884428902517
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.11700884428902517
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.11700884428902517
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001759633	0.11700884428902517
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.11700884428902517
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.11700884428902517
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.11700884428902517
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.11700884428902517
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.001759633	0.11700884428902517
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00111359	0.07404946310498584
COFFIN-SIRIS SYNDROME 10; CSS10	0.00111359	0.07404946310498584
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.07404946310498584
NEMALINE MYOPATHY 7; NEM7	0.00111359	0.07404946310498584
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.07404946310498584
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00111359	0.07404946310498584
ARTERIAL TORTUOSITY SYNDROME	0.00111359	0.07404946310498584
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.07404946310498584
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00111359	0.07404946310498584
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00111359	0.07404946310498584
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.07404946310498584
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00111359	0.07404946310498584
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00111359	0.07404946310498584
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00111359	0.07404946310498584
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00111359	0.07404946310498584
PIERSON SYNDROME	0.00111359	0.07404946310498584
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00111359	0.07404946310498584
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00111359	0.07404946310498584
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00111359	0.07404946310498584
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00111359	0.07404946310498584
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00111359	0.07404946310498584
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00111359	0.07404946310498584
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00111359	0.07404946310498584
GLYCOGEN STORAGE DISEASE IXB	0.00111359	0.07404946310498584
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.07404946310498584
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00111359	0.07404946310498584
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00111359	0.07404946310498584
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00111359	0.07404946310498584
JOUBERT SYNDROME 4	0.00111359	0.07404946310498584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.07404946310498584
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00111359	0.07404946310498584
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00111359	0.07404946310498584
AICARDI SYNDROME; AIC	0.00111359	0.07404946310498584
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00111359	0.07404946310498584
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.07404946310498584
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00111359	0.07404946310498584
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.00111359	0.07404946310498584
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00111359	0.07404946310498584
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00111359	0.07404946310498584
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00111359	0.07404946310498584
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00111359	0.07404946310498584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00111359	0.07404946310498584
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00111359	0.07404946310498584
EPILEPSY, HOT WATER, 1	0.00111359	0.07404946310498584
GLYCOGEN STORAGE DISEASE IXC	0.00111359	0.07404946310498584
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.07404946310498584
ACID PHOSPHATASE DEFICIENCY	0.00111359	0.07404946310498584
GLYCOGEN STORAGE DISEASE IV	0.00111359	0.07404946310498584
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00111359	0.07404946310498584
ETHANOLAMINOSIS	0.00111359	0.07404946310498584
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00111359	0.07404946310498584
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00111359	0.07404946310498584
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.07404946310498584
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00111359	0.07404946310498584
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00111359	0.07404946310498584
MYOPATHY, CENTRONUCLEAR, 5	0.00111359	0.07404946310498584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00111359	0.07404946310498584
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00111359	0.07404946310498584
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00111359	0.07404946310498584
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00111359	0.07404946310498584
BETHLEM MYOPATHY 2; BTHLM2	0.00111359	0.07404946310498584
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.07404946310498584
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00111359	0.07404946310498584
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00111359	0.07404946310498584
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00111359	0.07404946310498584
PORPHYRIA, ACUTE HEPATIC	0.00111359	0.07404946310498584
HYPERCALCEMIA, INFANTILE, 1	0.00111359	0.07404946310498584
LIVER FAILURE, INFANTILE, TRANSIENT	0.00111359	0.07404946310498584
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00111359	0.07404946310498584
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00111359	0.07404946310498584
PEROXISOME BIOGENESIS DISORDER 11B	0.00111359	0.07404946310498584
CHITAYAT SYNDROME	0.00111359	0.07404946310498584
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00111359	0.07404946310498584
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.07404946310498584
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00111359	0.07404946310498584
JOUBERT SYNDROME 5	0.00111359	0.07404946310498584
CEREBELLAR HYPOPLASIA	0.00111359	0.07404946310498584
LEGIUS SYNDROME	0.00111359	0.07404946310498584
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00111359	0.07404946310498584
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.07404946310498584
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00111359	0.07404946310498584
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00111359	0.07404946310498584
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.07404946310498584
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00111359	0.07404946310498584
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00111359	0.07404946310498584
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00111359	0.07404946310498584
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.07404946310498584
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00111359	0.07404946310498584
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00111359	0.07404946310498584
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.07404946310498584
SPINOCEREBELLAR ATAXIA 13	0.00111359	0.07404946310498584
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00111359	0.07404946310498584
DYSTONIA 11, MYOCLONIC	0.00111359	0.07404946310498584
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.07404946310498584
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00111359	0.07404946310498584
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00111359	0.07404946310498584
GLYCOGEN STORAGE DISEASE II	0.00111359	0.07404946310498584
PERRAULT SYNDROME 3	0.000915751	0.06089392854448575
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.06089392854448575
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.06089392854448575
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.06089392854448575
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.06089392854448575
EPILEPSY-TELANGIECTASIA	0.000915751	0.06089392854448575
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.06089392854448575
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.06089392854448575
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.06089392854448575
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.06089392854448575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.06089392854448575
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.06089392854448575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.06089392854448575
HYPERLYSINEMIA, TYPE I	0.000915751	0.06089392854448575
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.06089392854448575
DIAMINOPENTANURIA	0.000915751	0.06089392854448575
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.06089392854448575
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.06089392854448575
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.06089392854448575
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.06089392854448575
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.06089392854448575
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.06089392854448575
HUNTINGTON DISEASE; HD	0.000915751	0.06089392854448575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.06089392854448575
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.06089392854448575
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.06089392854448575
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.06089392854448575
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.000915751	0.06089392854448575
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.06089392854448575
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.06089392854448575
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.06089392854448575
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.06089392854448575
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.06089392854448575
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.06089392854448575
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.06089392854448575
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.06089392854448575
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.06089392854448575
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.06089392854448575
DARIER-WHITE DISEASE; DAR	0.000915751	0.06089392854448575
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.06089392854448575
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.06089392854448575
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000915751	0.06089392854448575
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.06089392854448575
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.06089392854448575
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.06089392854448575
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.06089392854448575
HYPER-BETA-ALANINEMIA	0.000915751	0.06089392854448575
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.06089392854448575
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.06089392854448575
SNEDDON SYNDROME	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.06089392854448575
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.06089392854448575
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.06089392854448575
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.06089392854448575
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.06089392854448575
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.06089392854448575
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.06089392854448575
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.06089392854448575
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.06089392854448575
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.06089392854448575
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.06089392854448575
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.06089392854448575
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.06089392854448575
KIFAFA SEIZURE DISORDER	0.000915751	0.06089392854448575
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.06089392854448575
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.06089392854448575
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.06089392854448575
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.06089392854448575
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.06089392854448575
KUFOR-RAKEB SYNDROME	0.000915751	0.06089392854448575
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.06089392854448575
GITELMAN SYNDROME	0.000915751	0.06089392854448575
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.06089392854448575
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.06089392854448575
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.06089392854448575
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.06089392854448575
PARIETAL FORAMINA	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.06089392854448575
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.000915751	0.06089392854448575
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.06089392854448575
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.06089392854448575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000915751	0.06089392854448575
1p36 microdeletion syndrome	0.000915751	0.06089392854448575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.06089392854448575
THREONINEMIA	0.000915751	0.06089392854448575
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.06089392854448575
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.06089392854448575
THYROCEREBRORETINAL SYNDROME	0.000915751	0.06089392854448575
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.06089392854448575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.06089392854448575
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.06089392854448575
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.06089392854448575
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.06089392854448575
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.06089392854448575
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.06089392854448575
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.06089392854448575
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.06089392854448575
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.06089392854448575
ALEXANDER DISEASE	0.000915751	0.06089392854448575
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.06089392854448575
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.06089392854448575
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.06089392854448575
HYPERPROLINEMIA, TYPE II	0.000915751	0.06089392854448575
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.06089392854448575
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.06089392854448575
Fabry disease	0.000915751	0.06089392854448575
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.06089392854448575
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.06089392854448575
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.06089392854448575
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.06089392854448575
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.06089392854448575
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.06089392854448575
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.06089392854448575
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.06089392854448575
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.06089392854448575
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.06089392854448575
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.06089392854448575
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.06089392854448575
IMMUNODEFICIENCY 47	0.000915751	0.06089392854448575
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.06089392854448575
RAMON SYNDROME	0.000915751	0.06089392854448575
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.06089392854448575
EPILEPSY, READING	0.000915751	0.06089392854448575
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.06089392854448575
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.06089392854448575
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.06089392854448575
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.06089392854448575
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.06089392854448575
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.06089392854448575
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.000915751	0.06089392854448575
AUTISM	0.000915751	0.06089392854448575
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.06089392854448575
Angelman syndrome (Type 2)	0.000915751	0.06089392854448575
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.06089392854448575
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.06089392854448575
PAPILLORENAL SYNDROME	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.06089392854448575
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.06089392854448575
FOUNTAIN SYNDROME	0.000915751	0.06089392854448575
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.06089392854448575
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.06089392854448575
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.06089392854448575
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.06089392854448575
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.06089392854448575
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.06089392854448575
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.06089392854448575
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.06089392854448575
CROME SYNDROME	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.06089392854448575
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.06089392854448575
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000915751	0.06089392854448575
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.06089392854448575
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.06089392854448575
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.06089392854448575
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.06089392854448575
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.06089392854448575
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.06089392854448575
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.06089392854448575
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.06089392854448575
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.06089392854448575
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.06089392854448575
TUBEROUS SCLEROSIS 2; TSC2	0.000915751	0.06089392854448575
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.06089392854448575
SECKEL SYNDROME 7; SCKL7	0.000915751	0.06089392854448575
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000915751	0.06089392854448575
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.06089392854448575
2q33.1 deletion syndrome	0.000915751	0.06089392854448575
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.06089392854448575
KEUTEL SYNDROME; KTLS	0.000915751	0.06089392854448575
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.06089392854448575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.06089392854448575
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.06089392854448575
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.06089392854448575
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.06089392854448575
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.06089392854448575
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.06089392854448575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.06089392854448575
TUBEROUS SCLEROSIS	0.000915751	0.06089392854448575
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.06089392854448575
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.06089392854448575
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.06089392854448575
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000915751	0.06089392854448575
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.06089392854448575
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.06089392854448575
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.06089392854448575
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.06089392854448575
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.06089392854448575
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.06089392854448575
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.06089392854448575
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.06089392854448575
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.06089392854448575
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.06089392854448575
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.06089392854448575
PHENYLKETONURIA	0.000915751	0.06089392854448575
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.06089392854448575
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.06089392854448575
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.06089392854448575
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.06089392854448575
Angelman syndrome (Type 1)	0.000915751	0.06089392854448575
GURRIERI SYNDROME	0.000915751	0.06089392854448575
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.06089392854448575
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.06089392854448575
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.06089392854448575
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.06089392854448575
STURGE-WEBER SYNDROME	0.000915751	0.06089392854448575
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.06089392854448575
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.06089392854448575
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000915751	0.06089392854448575
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000915751	0.06089392854448575
Wolf-Hirschhorn Syndrome	0.000915751	0.06089392854448575
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.06089392854448575
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.06089392854448575
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.06089392854448575
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.06089392854448575
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.06089392854448575
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.06089392854448575
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.06089392854448575
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.06089392854448575
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.06089392854448575
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.06089392854448575
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.06089392854448575
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.06089392854448575
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.06089392854448575
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.06089392854448575
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.06089392854448575
KRABBE DISEASE	0.000915751	0.06089392854448575
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.06089392854448575
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.06089392854448575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.056114915744539424
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.056114915744539424
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.056114915744539424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.056114915744539424
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.056114915744539424
BARATELA-SCOTT SYNDROME	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.056114915744539424
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.056114915744539424
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.056114915744539424
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.056114915744539424
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.056114915744539424
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.056114915744539424
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.056114915744539424
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.056114915744539424
300270 ADRENOMYODYSTROPHY	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.056114915744539424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.056114915744539424
HYDROXYKYNURENINURIA	0.000843882	0.056114915744539424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.056114915744539424
SECKEL SYNDROME 9; SCKL9	0.000843882	0.056114915744539424
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.056114915744539424
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.056114915744539424
Congenital disorder of glycosylation, type IIh	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.056114915744539424
Cerebral creatine deficiency syndrome 3	0.000843882	0.056114915744539424
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.056114915744539424
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.056114915744539424
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.056114915744539424
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.056114915744539424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.056114915744539424
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.056114915744539424
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.056114915744539424
#170100 PROLIDASE DEFICIENCY	0.000843882	0.056114915744539424
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.056114915744539424
MECKEL SYNDROME 13; MKS13	0.000843882	0.056114915744539424
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.056114915744539424
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.056114915744539424
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.056114915744539424
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.056114915744539424
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.056114915744539424
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.056114915744539424
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.056114915744539424
Leukotriene C4 synthase deficiency	0.000843882	0.056114915744539424
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.056114915744539424
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.056114915744539424
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.056114915744539424
#300555 DENT DISEASE 2	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.056114915744539424
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.056114915744539424
PELLAGRA-LIKE SYNDROME	0.000843882	0.056114915744539424
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.056114915744539424
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000843882	0.056114915744539424
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.056114915744539424
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.056114915744539424
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.056114915744539424
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.056114915744539424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.056114915744539424
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.056114915744539424
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.056114915744539424
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.056114915744539424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.056114915744539424
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.056114915744539424
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.056114915744539424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.056114915744539424
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.056114915744539424
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.056114915744539424
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.056114915744539424
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.056114915744539424
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.056114915744539424
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.056114915744539424
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.056114915744539424
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.056114915744539424
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.056114915744539424
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.056114915744539424
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.056114915744539424
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.056114915744539424
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.056114915744539424
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.056114915744539424
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.056114915744539424
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.056114915744539424
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.056114915744539424
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.056114915744539424
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.056114915744539424
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.056114915744539424
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.056114915744539424
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.056114915744539424
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.056114915744539424
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.000843882	0.056114915744539424
NETHERTON SYNDROME; NETH	0.000843882	0.056114915744539424
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.056114915744539424
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.056114915744539424
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.056114915744539424
CURRARINO SYNDROME	0.000843882	0.056114915744539424
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.056114915744539424
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.000843882	0.056114915744539424
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.056114915744539424
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.056114915744539424
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.056114915744539424
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.056114915744539424
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.056114915744539424
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.056114915744539424
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000843882	0.056114915744539424
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.056114915744539424
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.056114915744539424
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.056114915744539424
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.056114915744539424
FRIAS SYNDROME	0.000843882	0.056114915744539424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.056114915744539424
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.056114915744539424
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.056114915744539424
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.056114915744539424
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.056114915744539424
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.056114915744539424
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.056114915744539424
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.056114915744539424
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.056114915744539424
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.056114915744539424
OROTIC ACIDURIA	0.000843882	0.056114915744539424
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.056114915744539424
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000843882	0.056114915744539424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.056114915744539424
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.056114915744539424
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.056114915744539424
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.056114915744539424
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.056114915744539424
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.056114915744539424
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000843882	0.056114915744539424
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.056114915744539424
REVESZ SYNDROME	0.000843882	0.056114915744539424
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.056114915744539424
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.056114915744539424
Jawad syndrome	0.000843882	0.056114915744539424
BETA-UREIDOPROPIONASE DEFICIENCY	0.000843882	0.056114915744539424
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.056114915744539424
AUSTRALIA ANTIGEN	0.000843882	0.056114915744539424
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.056114915744539424
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.056114915744539424
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.056114915744539424
Bardet-Biedl syndrome 2	0.000843882	0.056114915744539424
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.056114915744539424
LISSENCEPHALY 2; LIS2	0.000843882	0.056114915744539424
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000843882	0.056114915744539424
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.000843882	0.056114915744539424
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.056114915744539424
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.056114915744539424
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.056114915744539424
LOWRY-MACLEAN SYNDROME	0.000843882	0.056114915744539424
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.056114915744539424
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.056114915744539424
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.056114915744539424
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.056114915744539424
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.056114915744539424
WAARDENBURG-SHAH SYNDROME	0.000843882	0.056114915744539424
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.056114915744539424
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.056114915744539424
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.056114915744539424
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.056114915744539424
ALSTROM SYNDROME; ALMS	0.000843882	0.056114915744539424
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.056114915744539424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.056114915744539424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000843882	0.056114915744539424
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.056114915744539424
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.056114915744539424
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.056114915744539424
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.056114915744539424
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.056114915744539424
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.056114915744539424
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.056114915744539424
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.056114915744539424
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.056114915744539424
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.056114915744539424
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.056114915744539424
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.056114915744539424
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.056114915744539424
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.000843882	0.056114915744539424
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.056114915744539424
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.056114915744539424
